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Abstract 
 
The formation of large, complex structures from small building blocks through self-assembly 
is widely seen in proteins and provides a tool for the creation of functional nanoscale 
devices. However, the factors controlling protein self-assembly are complex and often poorly 
understood. Peroxiredoxins are a large family of proteins, many of which are able to form a 
variety of large structures from a small, basic unit. This assembly has been shown to be 
strongly influenced by the redox state of the enzyme, which functions as a switch, controlling 
self-assembly. This thesis uses a protein from this family, human peroxiredoxin 3 (hPrx3) as 
a model system to investigate whether the self-assembly properties of hPrx3 can be 
influenced by rational protein engineering. 
Three forms of hPrx3 were purified and examined. These were the wild type and two 
variants: a mutant (S78A) and a His-tagged form. Size exclusion chromatography showed 
that each form showed a different ratio of dimers and larger species. Both variants showed 
preference for larger species, especially in the His-tagged form. This was shown to be 
partially dependent on metal binding in the His-tagged form. Larger species formed from 
multiple rings were also identified. SAXS measurement indicated that in the wild type 
enzyme, higher order species were dodecameric rings. For the His-tagged variant, SAXS 
measurement showed that the species observed had a different structure than that of the 
wild type. Electron microscopy showed that higher order structures seen in both wild type 
hPrx3 and His-tagged hPrx3 were ring shaped, with dimensions consistent with 
dodecamers. A competitive assay showed that the wild type, with kcat/km values near 2 × 
107, consistent with published results. Both variant forms showed evidence of slightly higher 
activity than the wild type, indicating a link between activity and assembly. 
A peroxiredoxin from the thermophilic bacteria Thermus aquaticus, TaqPrx was also 
examined, in an attempt to investigate a peroxiredoxin capable of self-assembly at high 
temperatures, which would be very useful for a nanoscale device. TaqPrx was cloned, 
purified and examined, however, no evidence of self-assembly was observed. Protein 
modelling and dynamic light scattering measurement indicated that the protein purified was 
monomeric and had a structure. Sparse matrix crystal screening identified conditions that 
allowed crystal formation, although strongly diffracting crystals were not produced. A novel 
assay for peroxiredoxin activity was developed, and suggested that TaqPrx shows 
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peroxiredoxin activity. This thesis shows that peroxiredoxins are a useful model system for 
the investigation of how protein self-assembly is controlled, and how it can be influenced by 
protein engineering.
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CHAPTER ONE 
Introduction 
 
 
Human peroxiredoxin 3 (hPrx3) is a protein that is able to form large, highly ordered 
structures from a small, dimeric building block through self-assembly. This thesis 
investigates what conditions affect self-assembly in hPrx3 and whether mutations can be 
used to alter the equilibrium, between oligomeric forms.  
1.1 Protein quaternary structure and self-assembly 
1.1.1 Quaternary structure 
Protein structure can be examined on several levels of increasing complexity. The sequence 
of amino acids in the polypeptide chain is the primary sequence. Amino acids interact to 
form secondary structural elements such as α-helices and β-sheets, which themselves 
assemble to form the three dimensional shape of a protein, its tertiary structure. Many 
proteins show a higher level of organisation, termed quaternary structure (Klotz, 
Langebman, and Dahnall 1970; Matthews and Sunde 2012). This is achieved by multiple 
polypeptide chains interacting permanently or transiently with each other to form larger 
structures (Ali and Imperiali 2005). The subunits in a protein complex may be identical, or a 
complex may be made up of multiple different types of subunit. Quaternary structures in 
proteins show a wide array of possible forms, from dimers made of two identical subunits 
(Marianayagam, Sunde, and Matthews 2004) to large, complex structures made of many 
different types of subunit, for example the F1F0 ATPases (Nakamoto, Baylis Scanlon, and Al-
Shawi 2008). 
1.1.2 Quaternary structure formation through self-assembly 
Quaternary structure in proteins is generally achieved by self-assembly (Figure 1.1) This is 
the ability of small units to assemble into a larger, ordered structure defined only by the 
structure of the subunits themselves (Whitesides and Boncheva 2002; Whitesides and 
Grzybowski 2002). In order to do this, proteins use interface regions to specifically and 
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stably interact with their binding partner. Interfaces between proteins vary widely in terms of 
area, residues and forces involved (Jones 2012). In general, interfaces with larger surface 
areas show stronger interactions (Horton and Lewis 1992), however, research has shown 
that different parts of an interface can contribute much more to its stability than others 
(Bogan and Thorn 1998).  
 
Figure 1.1: Schematic representation of self-assembly using proteins. (A) Amino acids assemble into 
(B) Secondary structural elements, which form (C) protein subunits, which themselves assemble to 
(D) oligomers. The image was created using PDB structures 1ZYE (Cao et al. 2005).  
The interfaces of many oligomers show a large number of polar residues able to form 
hydrogen bonds or ionic interactions across the interface (Sheinerman, Norel, and Honig 
2000). These may be direct, or mediated by water molecules trapped in cavities in the 
interface (Sonavane and Chakrabarti 2008). While these interactions are quite strong, 
residues must lose favourable interactions with the solvent, lessening their stabilising effect 
(Hendsch and Tidor 1994). Hydrophobic interactions, which increase stability by burying 
hydrophobic residues away from solution, are very important in the folding of a protein to its 
native form (Dill 1990). However, analysis of the role of hydrophobic interactions in assembly 
showed that its role is likely to be less important than that of hydrogen bonds and ionic 
interactions (Tsai et al. 1997). 
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Another important consideration is the three dimensional structure of the interface. In 
general, it has been seen that loop regions are more common in protein-protein interfaces 
than β-strands or α-helices (Ansari and Helms 2005). This may be due to the higher level of 
flexibility in these regions, allowing tighter, more stable interfaces to form (Jones 2012).  
1.1.3 Quaternary structure and protein function 
While it is known that many proteins form quaternary structures, the reasons for this are less 
well undersood (Griffin and Gerrard 2012). A variety of reasons have been proposed as to 
why oligomerisation is so widely observed.  
Some proteins show obvious functional benefits to assembly, such as having active sites 
located in interfaces between subunits (Marianayagam, Sunde, and Matthews 2004). This 
would allow for regulation of activity, as disrupting the interface would prevent enzyme 
activity. For structural proteins such as tubulin, formation from oligomers enhances a cell’s 
efficiency, as structures of varying lengths can be created by adding or removing subunits 
(Job, Valiron, and Oakley 2003). Another advantage for oligomerisation is increasing 
metabolic efficiency by substrate channelling. Several complexes made up of multiple 
different enzymes from the same metabolic pathway have been identified (Ovádi 1991). This 
allows substrates to pass from one active site to another without the risk of loss to competing 
reactions (Miles, Rhee, and Davies 1999). For many other proteins, no such obvious 
advantages to oligomerisation are known. It has been proposed that oligomerisation can 
influence protein dynamics in the active site (Griffin et al. 2008). 
1.2 Nanobiotechnology and protein self-assembly 
Nanobiotechnology is an emerging field of research aiming to utilise biological systems in 
the creation of devices at the nanometre scale that can carry out useful tasks (Whitesides 
2003; Lowe 2000). Biological systems contain extremely complex nanoscale systems. 
Examples are the F1F0 ATPase, a rotary molecular motor powered by an ion gradient 
(Nakamoto, Baylis Scanlon, and Al-Shawi 2008) and viral capsids, cage-like structures that 
encase the viral genome (Angelescu and Linse 2008). These structures are built from 
smaller subunits by self-assembly. By understanding the molecular basis of the assembly of 
these species, and how this assembly is controlled, biologically based nanodevices can be 
designed (Zhang 2003).  
Extensive work has been carried out in the use of DNA for this role: DNA can be folded into 
a wide range of two and three dimensional shapes using its ability to specifically bind to 
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complementary sequences (Rothemund 2006). Functional DNA based nanomachines have 
been demonstrated, such as walkers capable of moving along a  track (Bath and Turberfield 
2007). 
Proteins have also drawn attention as building blocks for nanoscales structures (Bromley et 
al. 2008; Papapostolou and Howorka 2009). Proteins have a unique set of properties that 
make them attractive as self-assembling building blocks. They possess diverse chemical 
functionality, and display a wide variety of three dimensional structures that could be used as 
the basis for nanoscale devices (Astier, Bayley, and Howorka 2005). 
As described in 1.1.2, the control of protein self-assembly is quite poorly understood, since 
many competing forces are involved. Thus, more extensive research is necessary to gain a 
better understanding of how protein self-assembly allows large structures to be built from 
smaller subunits. Peroxiredoxins are a family of proteins with members that show well 
defined self-assembly, as well as strong control of assembly based on their redox state. 
They can therefore be used as a model system by making changes to the protein and 
analysing how self-assembly is influenced. 
1.3 Overview of peroxiredoxins 
Peroxiredoxins (Prx) are a group of antioxidant enzymes found in all domains of life (Chae et 
al. 1994). First discovered in yeast (Kim et al. 1988), they have been shown to be present in 
almost every organism examined (Hofmann, Hecht, and Flohé 2005), with many producing 
multiple forms. Peroxiredoxins have been identified in the cytosol, membranes and inside 
organelles (Bernier-Villamor et al. 2004; Cao, Lindsay, and Isaacs 2007; Tavender, 
Sheppard, and Bulleid 2008), and are often among the most abundant proteins produced by 
both eukaryotic and bacterial cells (Rhee, Chae, and Kim 2005; Wood et al. 2003; Link, 
Robison, and Church 1997). The primary function of peroxiredoxin enzymes is to reduce 
peroxides, which are potentially damaging reactive oxygen species (ROS), formed as side 
reactions from the mitochondrial electron transport chain (Boveris and Chance 1973). 
However, peroxiredoxins have been implicated in numerous other roles, including cellular 
signalling (Wood, Poole, and Karplus 2003) and chaperone activity (Jang et al. 2004). 
Recent research has even shown evidence for a role of peroxiredoxin in the regulation of 
circadian rhythms (Edgar et al. 2012). The biological role of peroxiredoxins is discussed 
further in section 1.4. 
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Peroxiredoxins are unique among the several peroxide reducing enzymes in that they use 
no cofactors, relying instead on a conserved cysteine residue termed the peroxidatic 
cysteine, or CP. This reacts directly with peroxides to form an oxidised cysteine intermediate. 
The active enzyme is regenerated via a disulfide (Wood et al. 2003) using other enzymes in 
the cell as the reductant (Figure 1.2). 
 
Figure 1.2:  Basic reaction mechanism of peroxiredoxins. (A) The active cysteine reacts with 
hydrogen peroxide, forming the intermediate. (B) A disulfide is formed between the active cysteine 
and a second thiol group. (C) The active form is regenerated by reduction of the disulfide bond. CP is 
the active cysteine, Prx is the peroxiredoxin enzyme, R is a thiol containing species. 
Peroxiredoxins show variation in the details of this mechanism. The identity of the thiol 
containing group used to generate the disulfide form varies widely, as does the reductant 
used to regenerate the active enzyme. Section 1.5 further discusses the mechanism of 
peroxiredoxins, while section 1.6 contains details on the differences between groups of 
enzymes within the peroxiredoxin family. 
Certain peroxiredoxin enzymes have been shown to form a wide range of complex 
oligomeric structures. These are built using self-assembly from small, basic subunits. The 
most commonly seen structure is a ring formed by multiple dimers, often a decamer. The 
assembly of these has been shown to be strongly linked to the redox state of the active 
cysteine residue (Alphey et al. 2000; Barranco-Medina, Lázaro, and Dietz 2009). This acts 
as part of a switch to change proteins between a state favouring the dimer and a state 
favouring the decamer  (Wood et al. 2002). Peroxiredoxin rings have themselves been 
shown to self-assemble into even larger structures, including stacks and tubes, catenanes 
and cage-like structures. The details of this self-assembly process from small subunits to 
large and complex species, and how it is linked to the mechanism of peroxiredoxin activity is 
discussed further in section 1.7.  
Peroxiredoxins have the ability to form complex and well ordered structures through self-
assembly, and show well understood redox based control over this process. This makes 
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them a useful model system to investigate how protein self-assembly can be controlled 
through rational design of mutations to the protein sequence. How this thesis will achieve 
this goal is described further in section 1.8. 
1.4 The biological role of peroxiredoxins 
1.4.1 Overview 
A large amount of research into the biological role of peroxiredoxins has been carried out, 
primarily in mammalian systems. Much of this research is beyond the scope of this review, 
so instead a brief overview will be given, with a focus on the biological role of structural 
changes in peroxiredoxin. 
Peroxiredoxins are just one of several enzyme families that react with peroxides. Others are 
the catalases, glutathione peroxidases and thioredoxins. This indicates the importance of 
ROS removal in biology. Of these, peroxiredoxins are often the most abundant, and many 
organisms express multiple different peroxiredoxin enzymes. Some organisms that have 
been modified not to express peroxiredoxins show severe symptoms (Lee et al. 2007), while 
others demonstrate no visible detrimental effects ( Li et al. 2007). Upregulation of 
peroxiredoxins has been associated with drug resistance in the pathogenic bacterium 
Mycobacterium tuberculosis (M. tuberculosis) (Guimarães et al. 2005) and certain cancers 
(Park et al. 2000).  
1.4.2 Peroxiredoxins as cellular antioxidants 
Peroxiredoxins were first identified by their ability to protect proteins from oxidative damage, 
indicating a role as antioxidants (Kim et al. 1988). Others peroxide reducing enzymes 
include the catalases and the glutathione peroxidases, which are both known to have very 
high reaction rates (Salvi et al. 2007; Ursini, Maiorino, and Gregolin 1985). Activity assays 
have shown that peroxiredoxin enzymes have similar levels of activity, with kcat/km on the 
order of 1×107 M-1s-1 (Ogusucu et al. 2007; Nelson et al. 2008). Due to their high abundance, 
it has been calculated that they react with almost all peroxide present in the cytosol of 
eukaryotes, (Winterbourn 2008) and around 90% of peroxide in the mitochondria (Cox, 
Winterbourn, and Hampton 2010). 
1.4.3 Peroxiredoxins as chaperones 
Certain peroxiredoxins have been investigated as chaperone proteins (Jang et al. 2004). 
Other small proteins with chaperone activity have been shown to have assembly properties 
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(Benesch et al. 2008), and peroxiredoxins have been hypothesised to be involved in the 
evolution of the chaperonin class of chaperones (Dekker, Willison, and Taylor 2011). An 
investigation into two very similar peroxiredoxins from yeast, cytosolic Prx 1 and Prx 2, found 
that oxidative stress and heat shock triggered both assembly into higher molecular weight 
structures (HMW) and an increase in chaperone activity, with a decrease in peroxide 
reducing ability (Yang et al. 2002). A crystal structure of a peroxiredoxin in its HMW form has 
been published, and is formed by two stacked decameric rings (Saccoccia et al. 2012). 
 A study of mammalian Prx1 and Prx2 showed that the Prx1 had higher chaperone activity, 
while Prx2 had higher antioxidant activity, even though the enzymes are  91% homologous 
(Lee et al. 2007). They also showed differences in oligomeric state, with Prx1 favouring 
larger assemblies. This was found to be caused by a cysteine residue unrelated to the active 
site that could form disulfide bonds between proteins.  Mutation of this residue reduced the 
chaperone activity of Prx1 as well as its preference for the formation of larger species. 
1.4.4 Overoxidation and the floodgate model 
Several eukaryotic peroxiredoxins show susceptibility to overoxidation peroxide (Figure 1.3) 
(Yang et al. 2002). Unusually, this appears to be a derived trait – only a few prokaryotic 
peroxiredoxins are susceptible (Pascual et al. 2010), although extremely high concentrations 
of peroxide can cause overoxidation in any peroxiredoxin (Parsonage et al. 2005). Moreover, 
overoxidation susceptibility is strongly conserved across eukaryotic species. This has led to 
a hypothesis that overoxidation has a functional explanation in hydrogen peroxide signalling 
(Wood, Poole, and Karplus 2003). It is known that hydrogen peroxide is used in eukaryotic 
cells as a signalling molecule, with diverse biological roles (Veal, Day, and Morgan 2007). 
These include the regulation of the mitogen activated protein kinase and nuclear factor κB, 
which are involved in apoptosis (Allen and Tresini 2000).  
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Figure 1.3 Overoxidation of peroxiredoxin. (A) The standard peroxiredoxin cycle. CP is the 
peroxidatic cysteine, Prx is peroxiredoxin, R is a thiol containing species. (B) Reaction of the cysteine 
sulfenic acid intermediate with hydrogen peroxide forms a cysteine sulfinic acid. 
The floodgate model is a hypothesis that attempts to explain this (Wood, Poole, and Karplus 
2003). In the model peroxide levels are kept low by the actions of peroxiredoxins, as well as 
the other antioxidant enzymes under normal conditions. However when hydrogen peroxide 
levels are increased in a signalling event, peroxiredoxins are quickly overoxidised and 
inactivated. The normal, low flux of hydrogen peroxide produced by cell metabolism is 
prevented from activating hydrogen peroxide regulated pathways. This may explain the 
upregulation of peroxiredoxins in certain cancers – an increase in hydrogen peroxide would 
not overoxidise enough peroxiredoxins to activate the pro-apoptotic signal (Wood, Poole, 
and Karplus 2003; Cao, Bhella, and Lindsay 2007). 
The floodgate model was strengthened by the discovery that overoxidised peroxiredoxin was 
rapidly reactiviated in the cytosol (Woo et al. 2003). This was found to be due to a protein 
called sulfiredoxin (Biteau, Labarre, and Toledano 2003), which reduces cysteine sulfinic 
acids at the cost of ATP. 
There has been criticism of the floodgate model, however, as no evidence of overoxidised 
peroxiredoxin has been identified during peroxide mediated cell signalling (Cox, 
Winterbourn, and Hampton 2010). 
1.5 The peroxiredoxin mechanism and active site 
1.5.1 Peroxiredoxin substrate preference 
Peroxiredoxins react primarily with hydrogen peroxide, which is mainly produced by side 
reactions of oxygen in the mitochondria (Boveris and Chance 1973). However, activity with 
Chapter One: Introduction   9 
 
other peroxide species has been identified. Organic peroxides (ROOH) such as tBuOOH 
have been shown to react with certain peroxiredoxins (Cao, Bhella, and Lindsay 2007; 
Trujillo, Clippe, et al. 2007). Similar molecules are produced in organisms by the reaction of 
hydrogen peroxide with metabolites such as lipids and peptides. There is some evidence for 
peroxiredoxins reacting with these molecules in vivo (Cox, Winterbourn, and Hampton 
2010). Another species that peroxiredoxins have shown reactivity towards is peroxynitrite 
(ONOO-) (Manta et al. 2009; Bryk, Griffin, and Nathan 2000; Trujillo, Ferrer-Sueta, et al. 
2007). Peroxinitrite is formed by the reaction of the signalling molecule nitrous oxide (NO) 
with either the superoxide radical anion (O2
-) or hydrogen peroxide. It is highly reactive and 
capable of nitrating various organic molecules (Pacher, Beckman, and Liaudet 2007; Ferrer-
Sueta and Radi 2009). 
There appears to be variation between peroxiredoxins in substrate reactivity, with some 
being shown to prefer H2O2, while others react with peroxynitrite or organic peroxides (Bryk, 
Griffin, and Nathan 2000). 
1.5.2 Peroxiredoxin active site 
All peroxiredoxins have an active site architecture using four conserved amino acid residues 
(Figure 1.4A). These are the peroxidatic cysteine residue, also called CP, a proline residue, a 
threonine residue (in some cases a serine) and an arginine residue (Chae et al. 1994). 
These are very strongly spatially conserved in an active site pocket, with all but the arginine 
located in a conserved motif: PXXXT(/S)XXC. The arginine residue is located in a distant 
part of the protein sequence (Hall et al. 2010).  
The thiol group of the cysteine residue is thought to be deprotonated, in the thiolate form, 
which better allows a nucleophilic attack on peroxides (Alphey et al. 2000). While a standard 
cysteine thiol group has a pKa near 8, the active cysteine in peroxiredoxins has been shown 
to a significantly lower pKa, leading to a calculated 90% of CP thiol deprotonated (Nelson et 
al. 2008; Hugo et al. 2009).  
The thiolate form is stabilised primarily by the positively charged conserved arginine residue 
(Figure 1.4B), which is locked into orientation by nearby residues, usually a histidine or a 
glutamine residue (Hall et al. 2010; Karplus and Hall 2007). Furthermore, CP is located near 
the N-terminus of an alpha helix, which has an overall dipole moment due to the alignment of 
hydrogen bonds within the helix (Hol, Duijnen, and Berendsen 1978). The N-terminus has a 
positive dipole, helping to stabilise the negatively charged thiolate. Structural alignment of 
numerous peroxiredoxin crystal structures including molecules bound in the active site 
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shows that the conserved threonine (or serine) accepts a hydrogen bond from the peroxide 
substrate. This draws electron density away from the peroxide oxygen, activating it for 
nucleophilic attack by CP. The role of the conserved proline appears to be to block CP from 
the surrounding solvent (Hall et al. 2010; Nelson et al. 2011). 
   
Figure 1.4: (A) The peroxiredoxin active site, the conserved Cys, Thr, Arg and Pro residues are 
labelled (from PDB file 1ZYE (Cao et al. 2005)). (B) Schematic representation of the active site with 
hydrogen peroxide bound. Hydrogen bonds are represented as dashed bonds. 
1.5.3 Peroxiredoxin catalytic cycle 
The peroxiredoxin catalytic cycle can be divided into three steps (Figure 1.2). These are: 
peroxidation – the reaction of CP with peroxide to form an oxidised cysteine derivative called 
a cysteine sulfenic acid; resolution – the reaction of the cysteine sulfenic acid with another 
thiol to form a disulfide bond; and reduction – the regeneration of the initial thiolate form of 
CP (Wood et al. 2002). The first step is identical in all peroxiredoxins, but the next two can be 
accomplished in a variety of ways, depending on the enzyme. 
There are two ways in which the resolution step can occur. Most peroxiredoxins use a 
second cysteine residue located elsewhere in the amino acid sequence. These 
peroxiredoxins are termed 2-Cys Prx (Poole 2007). Many of these enzymes are dimers, and 
use a cysteine residue from the other subunit for resolution. The location of this residue in 
the protein sequence is generally conserved, and enzymes using this method of resolution 
are termed typical 2-Cys Prx. Other enzymes use a cysteine residue in the same peptide 
chain as the peroxidatic cysteine for resolution, and are termed atypical 2-Cys. The location 
of the resolving cysteine is not conserved across this group. The second way in which 
resolution can occur is through a mixed disulfide bond between the peroxidatic cysteine and 
another species, such as the thiol containing protein glutaredoxin (Pedrajas et al. 2010). 
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Peroxiredoxins that use this method of resolution are termed 1-Cys Prx. These differences 
are summarised in Figure 1.5. 
 
Figure 1.5: Differences in  the resolution step between peroxiredoxins. (A) The peroxidation step 
shared by all peroxiredoxins. The peroxidatic cysteine reacts with hydrogen peroxide to form a 
cysteine sulfenic acid. CP is the peroxidatic cysteine, Prx is the peroxidatic cysteine. (B) The 
resolution step in typical 2-Cys Prx. The cysteine sulfenic acid from one subunit reacts with the 
resolving cysteine from another subunit to form an intermolecular disulfide bond. Prxa and Prxb are 
two separate chains in a dimeric peroxiredoxin, CR is the resolving cysteine. (C) The resolution step in 
atypical 2-Cys Prx. The cysteine sulfenic acid reacts with a resolving cysteine on the same chain to 
form a intramolecular disulfide bond. (D) The resolution step in 1-Cys Prx. The cysteine sulfenic acid 
reacts with a thiol containing species to form a mixed disulfide bond. 
Reduction is accomplished by a variety of different enzymes, but reducing power is 
ultimately derived from NADPH or NADH (Poole 2005). This is achieved by forming an 
intermolecular disulfide with the oxidised peroxiredoxin, which is then reduced by the 
flavomolecule (Hofmann, Hecht, and Flohé 2005). In mammals, thioredoxin is used to 
reduce the peroxiredoxin. This effectively passes the oxidation onto thioredoxin, which is 
itself reduced by thioredoxin reductase (Cao, Bhella, and Lindsay 2007). AhpC proteins, 
which are a group of peroxiredoxins found in bacteria, use an enzyme called AhpF to reduce 
them, which combines the activities of thioredoxin and thioredoxin reductase (Poole et al. 
2000). Some organisms use different systems – parasitic trypanosomatids use a unique 
peptide  called trypanothione and an enzyme called tryparedoxin, which has some 
similarities to thioredoxin (Nogoceke et al. 1997). 
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1.5.4 Rate of reaction 
Peroxiredoxins have generally be shown to have high rates of reaction similar magnitude to 
other peroxide reducing enzymes such as catalase (Schonbaum and Chance 1976). This is 
accomplished by the stabilisation of the transition state of the peroxidation step (1.5.3). 
Neither the starting materials (the cysteine thiolate and peroxide) or the products (the 
cysteine sulfenic acid and a hydroxyl anion) can form optimal hydrogen bonds in the active 
site (Hall et al. 2010). 
1.6 Peroxiredoxin classes 
The peroxiredoxin family of enzymes is large, and can be divided up into several groups. 
Peroxiredoxin naming is not consistent through the literature, especially in earlier research, 
when fewer examples were well studied. The first way that peroxiredoxins were categorised 
was by their mechanism of H2O2 reduction, specifically how they accomplish resolution of 
the cysteine sulfenic acid form. As described in 1.5.3, this gives three groups: typical 2-Cys, 
atypical 2-Cys and 1-Cys peroxiredoxins (Barranco-Medina, Lázaro, and Dietz 2009). 
1.6.1 Sequence based divisions 
Examination of sequences and crystal structures showed that the mechanism based 
divisions of peroxiredoxins do not accurately represent the evolutionary relationships within 
the family. Using sequence alignments, peroxiredoxins were divided into 6 groups (Karplus 
and Hall 2007; Hall et al. 2011). These do not preserve the previous 1-Cys/2-Cys, 
typical/atypical divisions – many groups contain examples of multiple types, indicating that 
certain features have arisen multiple times in the course of the evolutionary history of these 
proteins. 
AhpC-Prx1 is the best studied group and is named for two of the first peroxiredoxins 
investigated; the bacterial AhpC and the mammalian Prx1. This group is widely distributed, 
being found in archaea, bacteria and in every order of eukaryotes (Nelson et al. 2011). All 
AhpC-Prx1 peroxiredoxins are dimeric in their most basic form and use the typical 2-Cys 
mechanism (1.5.3) with the resolving cysteine located in a C-terminal extension. Some 
mammalian enzymes in this class show susceptibility to overoxidation in high concentrations 
of peroxide, which may be linked to cellular signalling (1.4.4). Many proteins in this group 
demonstrate intriguing self-assembly properties which are regulated by the redox state of the 
peroxidatic cysteine.  
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The BCP-PrxQ is a group found mainly in bacteria, though examples exist in plants and 
yeast. The name comes from bacterioferritin comigratory protein, a former name for 
peroxireodoxins, and the plant PrxQ. Many of these proteins are monomeric, though some 
dimeric forms have been identified (Nelson et al. 2011). This group contains proteins using 
both the atypical 2-Cys mechanism (D’Ambrosio et al. 2009) and the 1-Cys mechanism 
(Wakita et al. 2007). 
Prx6 is a group that is closely related to the AhpC-Prx1 group and is named after human 
peroxiredoxin 6. They are found in bacteria and eukaryotes. Prx6 peroxiredoxins are dimeric, 
but mainly use the 1-Cys Prx mechanism, although some use the typical 2-Cys mechanism 
(Deponte and Becker 2005). Another dimeric group is the Prx5 group, named after human 
Prx5. Found in bacteria and eukaryotes; the group mainly includes members that use the 1-
Cys Prx mechanism, though others use the atypical 2-Cy Prx mechanism. 
Two other groups exist; both contain very few known enzymes. The Tpx are named for thiol 
peroxidase, another former name for peroxiredoxins, and are found only in bacteria. They 
are dimeric and use the atypical 2-Cys Prx mechanism (Hall, Karplus, and Poole 2009). The 
AhpE peroxiredoxins are also dimeric, but use the 1-Cys Prx mechanism (Hugo et al. 2009). 
They are named for the first example of the group, which was discovered in M. tuberculosis 
(Li et al. 2005) and are found only in closely related bacteria. 
1.7 Peroxiredoxin structure and assembly 
1.7.1 Peroxiredoxin fold 
All peroxiredoxins share a similar structure called the thioredoxin fold, an α/β fold which is 
also seen in several other proteins that catalyse disulfide related reactions, including 
thioredoxin and glutathione peroxidase (Schröder and Ponting 1998). The core of this fold 
consists of 7 β-strands, forming a 5 stranded β-sheet (β3 to β7) and a β-hairpin (β1 and β2). 
As there is some interaction between the sheet and the hairpin, it is sometimes referred to 
as a 7 stranded β-sheet. The sheet is antiparallel, and is surrounded by 5 α-helices (Figure 
1.6A). The key reactive cysteine is located in the first turn of α2 (Figure 1.6B) (Choi et al. 
1998). Peroxiredoxins have been characterised in which the basic fold with differing loop 
lengths, and extensions at both the N- and C-termini (Schröder and Ponting 1998). 
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Figure 1.6: (A) The core structure of the peroxiredoxins, with secondary structural elements labelled.  
(B) Rotated image showing the location of the active site. The active site is highlighted in blue. The 
conserved active site residues are shown, and the peroxidatic cysteine is marked as CP. β-strands are 
shown in yellow, α-helices are shown in red. Images were created from PDB file 1ZYE (Cao et al. 
2005). 
1.7.2 Dimer formation 
Peroxiredoxins can form oligomers through two main interfaces. These are termed the A-
type and B-type interfaces. The A-type interface (Figure 1.7A) involves four regions of 
contact between four regions of the protein, which have been termed regions I to IV (Figure 
1.7B) (Wood et al. 2002). The main contributions to this interface are from the interaction 
between region I, which is the loop between β3 and α2, region II, which is α3. Region I 
borders on the active site of the enzyme, and is very important in the redox switching 
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behaviour seen in some peroxiredoxins (1.7.3). The A-type interface is more common across 
the peroxiredoxin family than the B-type interface, and shows considerable variation in the 
angle of the two groups (Sarma et al. 2005). 
The B-type interface is formed through β7 in an antiparallel arrangement, creating an 
extended β-sheet across the subunits of the dimer (Figure 1.7C). Enzymes using this 
interface have a C-terminal extension that helps provide stability to the dimer (Karplus and 
Hall 2007). This interface is seen only in the AhpC-Prx1 and Prx6 groups, where it forms the 
basic unit of the protein in these families (1.6.1). 
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Figure 1.7: (A) The A-type interface. Interacting regions are shown in red. (B) The B-type interface. 
Interacting regions are shown in red. (C) The A-type interface. Region I is shown in red, region II is 
shown in yellow, region III is shown in magenta and region IV is shown in orange. Images were 
created from PDB file 1ZYE (Cao et al. 2005). 
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1.7.3 Assembly of larger species 
Peroxiredoxins of the AhpC-Prx1 group have been shown to be able to form higher order 
species from dimers. Best known is the decameric form (Schröder et al. 2000), though 
octameric and dodecameric forms have also been identified (Figure 1.8A-C) (Li et al. 2005; 
Cao et al. 2005). These peroxiredoxins are B-type dimers, but use the A-type interface to 
assemble into ring shaped species that have been observed both by electron microscopy 
and X-ray crystallography. 
 
Figure 1.8: Oligomeric assemblies in peroxiredoxins. (A) An octomeric peroxiredoxin ring (PDB code 
2H01, unpublished). (B) Decameric peroxiredoxin ring (PDB code 1N8J, (Wood, Poole, and Karplus 
2003)). (C) Dodecameric peroxiredoxin ring (PDB code 1ZYE, (Cao et al. 2005)). (D) Stack of three 
dodecameric rings. Image from (Gourlay et al. 2003). (D) Catenane of dodecamers. Image was taken 
from (Cao et al. 2005). (E) Dodecahedron formed from decamers. Image from (Meissner et al. 2007). 
 
In several studies, a wide range of even larger structures have been identified that are 
assembled from ring shaped species (Figure 1.8C-E). The most common form seen is a 
stack of rings. These have been identified by transition electron microscopy (TEM), and may 
be anything from a pair of rings (Saccoccia et al. 2012), to a long tube built from as many as 
60 rings stacked on top of each other (Gourlay et al. 2003).  Other structures include a 
catenane formed of two interlocking dodecamers that was identified by X-ray crystallography 
(Cao et al. 2005), and a cage shape dodecahedral structure made of 12 decamers, identified 
by TEM (Meissner et al. 2007). Finally, regular but less well defined structures termed ‘high 
Chapter One: Introduction   18 
 
molecular weight complexes (HMW)’ have been identified in certain peroxiredoxins in 
response to increased oxidative stress (Jang et al. 2004).  
A recent X-ray structure has identified the interface giving rise to stacked species, 
which was termed the R-interface (Saccoccia et al. 2012). This main interactions 
involved are thought to be electrostatic (Figure 1.9). 
 
Figure 1.9: The proposed R- interface between decameric peroxiredoxin. Negatively charged regions 
are shown in blue, positively charged regions are shown in red.  Image was created from PDB file 
3ZTL (Saccoccia et al. 2012). 
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1.8 Control of AhpC-Prx1 self-assembly and protein dynamics 
1.8.1 The redox switch 
Several studies have investigated the conditions that favour self-assembly in peroxiredoxins 
that form higher order structures. A wide variety of factors have been implicated, including 
low pH, high or low ionic strength and increased protein concentration (Matsumura et al. 
2008; Bernier-Villamor et al. 2004; Kitano et al. 1999). The most important factor, however, 
is the redox state of the peroxidatic cysteine, with the reduced, dithiol form favouring higher 
order species, and the oxidised, disulfide form favouring the dimer (Wood et al. 2002; 
Barranco-Medina et al. 2008).This was found to be caused by movements in the region of 
the protein containing the active site, a region termed the CP loop.  
In the reduced form, this forms the first turn of the helix α2 and is directly adjacent to region I 
of the A-type interface (Figure 1.10A). When the enzyme is oxidised to the cysteine sulfenic 
acid intermediate form, the CP loop unfolds, allowing the resolving cysteine access to 
peroxidatic cysteine and the formation of the disulfide bond between them (Figure 1.10B) 
(Wood et al. 2002). However, this unfolding causes region I to shift, which destabilises the A-
type interface and disrupts the formation of larger, ring shaped species (Poole 2007). 
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Figure 1.10: (A) The A-type interface and the CP loop in the reduced form. The CP loop is shown in 
yellow, region I and II interfaces are shown in red, the subunit across the A-type interface is shown in 
cyan. The peroxidatic cysteine is labelled CP. (PDB code 1ZYE (Cao et al. 2005)). (B) The oxidised 
form. The CP loop is shown in yellow, region I is shown in red, the subunit across the B-type interface 
that contributes CR is shown in orange. The peroxidatic cysteine is labelled CP, the resolving cysteine 
is labelled CR. (PDB code 1QQ2 (Hirotsu et al. 1999)) 
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1.8.2 Protein dynamics in the catalytic cycle of peroxiredoxins 
When the peroxidatic cysteine reacts with its peroxide substrate, a local unfolding event 
occurs. This causes the CP loop on helix α2 to unfold, exposing the cysteine sulfenic acid to 
the solution. This can be seen in all crystal structures of oxidised peroxiredoxins, and allows 
the resolving cysteine residue to approach the normally buried CP (Karplus and Hall 2007). 
In the typical 2-Cys mechanism, the two cysteine residues involved in the reaction 
mechanism are very distant from each other – as much as 14 Å. Moreover, the resolving 
cysteine (CR) is buried within a subdomain formed by the C-terminal extension which these 
peroxiredoxins contain. In order to form the disulfide bond, further unfolding of the protein is 
necessary. After the formation of the cysteine sulfenic acid and the local unfolding that 
exposes it, the region containing CR also unfolds, allowing it to reach across the dimer 
interface and react to form the disulfide form (Figure 1.10B) (Wood et al. 2002).  
Local unfolding also plays a role in peroxiredoxins using the atypical 2-Cys Prx mechanism, 
though this has been investigated to a much lesser extent than those that use the typical 2-
Cys mechanism. There is great variation in resolving cysteine location in proteins that use 
this mechanism, ranging from a few amino acids away from the peroxidatic cysteine (Liao et 
al. 2009) to distances close to those seen in peroxiredoxins using the 2-Cys Prx (Hall, 
Karplus, and Poole 2009). However, the oligomerisation of peroxiredoxins using the atypical 
2-Cys mechanism is not affected by their redox conditions (Sarma et al. 2005; Hall, Karplus, 
and Poole 2009). 
1.8.3 The link between activity and oligomerisation 
The oligomeric state of AhpC-Prx1 family peroxiredoxins is strongly influenced by the redox 
state of the peroxidatic cysteine residue. As this residue changes its oxidation state as part 
of its catalytic cycle (Figure 1.2), it has been hypothesised that self-assembly of these are 
linked, and that the assembly of higher order species enhances the catalytic activity of 
peroxiredoxins (Barranco-Medina, Lázaro, and Dietz 2009). Mutations to residues in the A-
type interface have been shown to influence activity in AhpC, with mutants where the 
decameric form was less favoured showing lower activity than the wild-type, and a mutant 
where the decamer form was favoured showed higher activity (Parsonage et al. 2005). 
Chapter One: Introduction   22 
 
1.8.4 Overoxidation 
Several mammalian peroxiredoxins show a susceptibility to inactivation by excess hydrogen 
peroxide (1.4.4). This is caused by the cysteine sulfenic acid intermediate form reacting with 
hydrogen peroxide and forming a cysteine sulfinic acid (Figure 1.3) 
The basis for this is two conserved motifs that all overoxidation sensitive peroxiredoxins 
contain: Gly-Gly-Leu-Gly (GGLG) and Tyr-Phe (YF). GGLG is found between α3 and β5, 
and the YF motif is found in the C-terminal extension found in typical 2-Cys peroxiredoxins 
(Wood, Poole, and Karplus 2003). These are thought to make the local unfolding of the CP 
loop less favourable, allowing for the cysteine sulfenic acid to persist long enough to react 
with a further molecule of peroxide (Sayed and Williams 2004). Truncation of the C-terminal 
extension has been shown to prevent overoxidation (Koo et al. 2002) and it has been 
hypothesised that lower mobility in the C-terminal tail also contributes to overoxidation, by 
slowing down the reaction of CR with the cysteine sulfenic acid (Wood et al. 2002). As the CR 
cannot react with the sulfinic acid to form, overoxidised peroxiredoxins favour a decameric 
form (Schröder et al. 2000).  
1.9 Human Peroxiredoxin 3 
Human peroxiredoxin 3 (hPrx3) is found in the mitochondria, where it is responsible for the 
reduction for the majority of hydrogen peroxide generated there (Cox, Winterbourn, and 
Hampton 2010). The other peroxiredoxin in the mitochondria is peroxiredoxin 5, which is a 
member of the Prx5 group (1.5.1) and uses the atypical 2-Cys Prx mechanism (Cao, 
Lindsay, and Isaacs 2007). 
Peroxiredoxin 3 belongs to the AhpC-Prx1 group, and uses the typical 2-Cys Prx 
mechanism, as do all members of this group (Cao, Lindsay, and Isaacs 2007). It was first 
identified as MER 5 (Tohru et al. 1989) and was later termed SP-22 (Watabe et al. 1994) 
before being renamed hPrx3. It shows a similar level of activity to other peroxiredoxins, 
though tuned for the different pH conditions of the mitochondria (Cox et al. 2009). Like other 
mammalian AhpC-Prx1 peroxiredoxins, it contains the overoxidation motifs (1.8.4) and is 
susceptible to overoxidation, though to a slightly lesser extent than its closest relatives, 
human peroxiredoxins 1 and 2 (Cox, Winterbourn, and Hampton 2010). It also contains the 
residues proposed to allow the formation of stacked ring structures (Saccoccia et al. 2012). 
While little research has been carried out on the structure of human peroxiredoxin 3, the very 
similar bovine homolog has been examined by electron microscopy and X-ray 
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crystallography (Gourlay et al. 2003; Cao et al. 2005). These studies revealed that the 
protein formed ring shaped species, as well as stacks of two or three rings. Moreover, in a 
mutant replacing the active cysteine with a serine, long tubes of up to 60 rings were 
observed (Gourlay et al. 2003). A crystal structure of the bovine homolog has been 
published (Cao et al. 2005). This shows the protein forms a dodecameric ring (it was 
previously thought to be decameric), and also reveals a unique catenane arrangement, 
where two dodecameric rings interlock. 
1.10 Summary and project overview 
Peroxiredoxins are an enzyme family that use a conserved cysteine residue to reduce 
peroxides. Many display self-assembly that is strongly influenced by the redox state of the 
active site cysteine. This regulated self-assembly property makes it attractive as a model 
system to investigate how engineering of the protein can be used to influence self-assembly. 
Human peroxiredoxin 3 was selected for study as it demonstrates a wide variety of the 
unique oligomeric properties of peroxiredoxins. As an AhpC-Prx1 group peroxiredoxin, it 
shows self-assembly linked to the redox state of the enzyme active site. The closely related 
bovine Prx3 has been shown to form a wide range of higher order structures, including 
stacks, catenanes and tubes. 
This thesis aimed to investigate the self-assembly of hPrx3, and to examine whether 
modifications to the sequence of the protein could be used to alter these self-assembly 
properties. This could be through altering the proportions of dimers and ring shaped species 
observed; or by altering the chemical and physical conditions where different forms were 
favoured. 
There were also two secondary goals. First, to investigate whether any hPrx3 variants with 
altered self-assembly properties had altered enzymatic activity; and secondly, to investigate 
self-assembling thermophilic peroxiredoxins and identify any altered oligomeric properties 
they had compared to the wild type. 
Chapter Two describes the overexpression and purification of 4 different forms of hPrx3. 
These are the wild type enzyme, the hPrx3 S78A mutant, His-tagged hPrx3 and His-tagged 
hPrx3 S78A. It then describes the methods used to determine the oligomeric size and shape 
of the species observed, as well as an assay to find the Km/Kcat of each purified enzyme 
variant. 
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Chapter Three describes the identification of a potential peroxiredoxin enzyme in the 
genome of the thermophilic bacterium Thermus aquaticus, TaqPrx.  The gene coding for it 
was cloned into a plasmid and the protein was overexpressed and purified. The size and 
oligomeric state of the protein was investigated. A novel assay was designed in order to 
identify any evidence for peroxide reducing activity in TaqPrx.
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CHAPTER TWO 
Results and Discussion (hPrx3) 
 
Four forms of human peroxiredoxin 3 (hPrx3) were purified and analysed: wild type hPrx3; 
hPrx3 S78A, which contains a mutation in the A-type interface that forms ring shaped 
species such as decamers and dodecamers (1.7.3); His-tagged wild type; and His-tagged 
hPrx3 S78A. His-tagged hPrx3 S78A showed poor solubility, so limited work was carried out 
on this variant. These proteins were examined to determine their quaternary structure under 
various conditions and to investigate which higher order species the proteins could form. 
Protein activity was also examined to investigate whether differences in oligomeric state 
correlated with changes in the activity of the enzyme. 
The presence of N-terminal His-tags has previously been implicated in promoting 
oligomerisation in peroxiredoxins (Cao, Bhella, and Lindsay 2007). It was examined in order 
to further investigate its effects of peroxiredoxin self-assembly, and to investigate the 
mechanism for any effects on self-assembly observed.  
The mutant hPrx3 S78A contains a substitution in the A-type interface, which is used in the 
formation decamers and dodecamers (1.7.3). A mutation similar to this, T77V, was studied in 
a bacterial peroxiredoxin, where it was found to promote higher order structures (Parsonage 
et al. 2005). hPrx3 S78A was examined to investigate whether this property would also be 
observed. S78 is located in region II in the A-interface (1.7.2), and is thought to form water 
mediated hydrogen bonds across the interface. 
2.1 Purification 
Protein was purified following a protocol based of (Gourlay et al. 2003), as described in 6.2.  
This was modified by adding a His-tag cleavage step using tobacco etch virus (TEV) 
protease when purifying wild type hPrx3 and hPrx3 S78A. An anion exchange step was also 
added, as small amounts of contaminants were detected in early purifications. 
After incubation overnight, Escherichia coli (E. coli) BL21 cells were harvested by 
centrifugation and resuspended in buffer. A cell press was used to disrupt cell walls and cell 
debris was removed by centrifugation. Nickel affinity chromatography was used to separate 
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protein from the lysate. Protein was then dialysed and cleaved using TEV protease 
overnight. Cleaved protein was separated from His-tags, uncleaved protein and TEV 
protease using a second nickel affinity chromatography step, collecting protein that did not 
interact with the column. Finally, samples were dialysed and purified further using anion 
exchange chromatography, then dialysed into storage buffer.  
For His-tagged hPrx3 and His-tagged hPrx3 S78A, the TEV protease cleavage step was 
omitted. Samples separated from the bacterial lysate by nickel affinity chromatography were 
dialysed and purified by anion exchange chromatography, then dialysed into buffer. 
Purification efficiency was analysed using SDS-PAGE as described in 4.8.   
2.1.1 Purification of wild type hPrx3 and S78A 
 
Figure 2.1: Purification of wild type hPrx3. Lane 1: Novex Sharp prestained protein standards. Lane 
2: Bacterial lysate. Lane 3: Pellet from lysed bacteria. Lane 4: Nickel affinity column flowthrough. 
Lane 5:His-tagged hPrx3 after nickel affinity chromatography. Lane 6: His-tagged hPrx3 in TEV 
protease cleavage buffer. Lane 7: Uncleaved hPrx3, TEV protease and cleaved His-tags. Lane 8: 
hPrx3 after anion exchange chromatography. 
The size of the band seen in Lane 8 is slightly larger than 20 kDa. This is consistent with the 
molecular mass of hPrx3, which is 22.0 kDa. 
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Both hPrx3 and hPrx3 S78A were purified using the same method. A representative SDS-
PAGE gel is shown. For hPrx3, yields of up to 40 mg of protein per litre of culture were 
obtained. For hPrx3 S78A, yields of up to 25 mg of protein per litre of culture were obtained. 
2.1.2 Purification of His-tagged hPrx3 
 
Figure 2.2: Purification of His-tagged hPrx3. Lane1: His-tagged hPrx3 after anion exchange 
chromatography. Lane 2-3: His-tagged hPrx3 after nickel affinity chromatography. Lane 4: Nickel 
affinity column flowthrough. Lane 5: Pellet from lysed bacteria. Lane 6: Bacterial lysate. Lane 7: 
Precision Plus Protein WesternC prestatined protein standards. 
For His-tagged hPrx3, yields of up to 25 mg per litre of culture were obtained. In the final 
lane, a single band is present with a molecular mass of approximately 25 kDa, consistent 
with His-tagged hPrx3. 
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2.1.3 Purification of His-tagged hPrx3 S78A 
 
Figure 2.3: Purification of His-tagged hPrx3 S78A. Lane 1: Protein standards. Lane 2: Bacterial 
lysate. Lane 3: Pellet from lysed bacteria. Lane 4: Nickel affinity column flowthrough. Lane 5: 
Aggregated His-tagged hPrx3 S78A. 
When His-tagged hPrx3 S78A was dialysed into low salt buffer in preparation of anion 
exchange chromatography, rapid aggregation was observed. The aggregated species has a 
mass of approximately 25 kDa, consistent with His-tagged hPrx3 S78A, which has a 
calculated molecular mass of 25.2 kDa. 
2.2 Analysis of the quaternary structure of hPrx3 
In order to examine the oligomeric state of hPrx3, methods to determine the molecular 
weight of species present under varying buffer conditions were necessary. Analytical size 
exclusion chromatography (SEC), which separates protein by their hydrodynamic radius 
using a column of gel beads, was employed to obtain an approximate molecular mass as 
described in 6.4.1. By comparing the volume of buffer required to elute the sample protein to 
a set of standards of known molecular mass, an estimate of the molecular weight of the 
species present can be obtained (Porath and Flodin 1959). However, SEC assumes that the 
protein of interest is of a similar shape to those used to make the calibration curve. 
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Moreover, larger species are more prone to error than smaller species, as the relationship 
between elution volume and hydrodynamic radius is logarithmic (Winzor 2003). 
Despite these disadvantages, SEC offers the ability to screen a large range of different 
conditions, with few restrictions on buffer type. Additionally, the difference in mass between 
dimers and any higher order species present was expected to be large enough that 
meaningful results could be obtained despite the inherent limitation of the analytical method. 
        
 
Figure 2.4: (A) Absorbance at 280 nm of Bio-Rad protein standards in 20 mM Tris, 150 mM NaCl, pH 
7.5. Standards are, from left to right: Bovine thyroglobin (670 kDa); bovine γ-globulin (158 kDa); 
chicken ovalbumin (44 kDa); horse myoglobin (17 kDa); Vitamin B12 (1.35 kDa).The blue bar marks 
the void volume of the column, ~8 ml.  (B) Calibration curve of protein standards. 
 
Using the calibration curve, an equation to estimate the molecular mass of unknown 
samples can be derived. 
log10 (MW) = -0.22(x) + 8.22 
Where MW is the molecular mass of the species in Daltons, and x is the elution volume in 
ml. 
Several different SEC columns were used over the course of this thesis, each having slightly 
different volumes. When calculating masses, calibration curves appropriate to each column 
were used.  
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2.2.1 SEC analysis of hPrx3 
Protein was examined in 20 mM Tris, 150 mM NaCl, pH 7.5 in both the presence and 
absence of DTT as a reductant. Tris was selected as it is capable of buffering between pH 
7.5 and 9.0, so oligomeric state could be compared at both neutral and raised pH without 
altering buffer type. These peaks were then compared to the calibration curve in order to 
estimate their molecular mass. The calculated mass of the dimeric protein from the amino 
acid sequence is 44.1 kDa, while the decameric form is 220.5 kDa and the dodecameric 
form is 264.5 kDa. 
        
 
Figure 2.5: (A) Absorbance at 280 nm of hPrx3 in 20 mM Tris, 150 mM NaCl, pH 7.5. (B) Absorbance 
at 280 nm of hPrx3 in 20 mM Tris, 150 mM NaCl, 10 mM DTT, pH 7.5. 
The trace for the protein in the presence of reductant shows an uneven baseline. This is due 
to the presence of DTT, which absorbs strongly at 280 nm. 
For the protein in the absence of reductant, three peaks are present in the 10 mg/ml sample. 
The largest is close to, but not at the void volume. This corresponds to a species with a 
molecular mass of approximately 1 MDa. The second peak seen corresponds to a mass of 
approximately 390 kDa, while the third corresponds to a molecular mass of approximately 40 
kDa. The 5 mg/ml and 1 mg/ml samples only show peaks corresponding to approximately 40 
kDa. 
For protein in the presence of reductant, two main peaks can also be seen, corresponding to 
species of similar size to those seen in the non-reduced sample. However, the peak 
corresponding to the larger species is significantly larger, and is present even at the lowest 
protein concentration measured. 
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The smaller of the two main peaks likely corresponds to the dimeric form of the protein, while 
the larger is probably a higher order structure such as a decamer or dodecamer. The 
increased levels of higher order species present in reduced conditions is consistent with 
previously reported results for peroxiredoxins, where reduction favoured higher order 
species (Wood et al. 2002). While the value calculated for the dimer is close to that seen in 
the size exclusion graph, the higher order species appears to be significantly larger. 
Although this may be due to the protein forming a species other than the ring shaped 
species reported in the literature, it is more likely to be due to the ring structure moving 
through the gel matrix at a different rate than would be predicted for more spherical protein.  
Both conditions also showed a third, well defined peak at 10 mg/ml corresponding to an 
even larger species. While it is not possible to accurately determine the mass of such 
species using this technique, very large structures formed from peroxiredoxins have 
previously been reported (Jang et al. 2004). 
Samples were also examined in 20 mM sodium phosphate (NaPi), 150 mM NaCl, pH 7.5 
both in the presence and absence of reductant. NaPi is able to buffer at lower pH levels than 
Tris, and so was used to compare to samples examined in low pH conditions. 
        
 
Figure 2.6: (A) Absorbance at 280 nm of hPrx3 in 20 mM NaPi, 150 mM NaCl, pH 7.5. (B) 
Absorbance at 280 nm of hPrx3 in 20 mM NaPi, 150 mM NaCl, 10 mM DTT, pH 7.5. 
In the non-reduced conditions, two distinct peaks are present, at similar elution volumes to 
those seen for the protein in Tris at pH 7.5. These correspond to species with molecular 
masses of 390 kDa and 40 kDa. However, the ratio of species is different, with higher order 
species being favoured. This shows that buffer can have strong effects on the assembly of 
the protein into larger order structures. 
Chapter Two: Results and Discussion (hPrx3)  32 
 
In reduced conditions, two peaks are also present, with molecular weights of approximately 
370 kDa and 40 kDa. These most likely correspond to dimeric and higher order forms of the 
protein. In the 10 mg/ml trace, evidence of an even larger species is present, similar to what 
was observed in Figure 2.5. 
Samples were examined at increased pH levels, as the hPrx3 A-type interface (1.7.2) 
contains residues capable of forming hydrogen bonds, which could be strengthened or 
weakened by altering the pH. 
        
 
Figure 2.7: (A) Absorbance at 280 nm of hPrx3 in 20 mM Tris, 150 mM NaCl, pH 9.0. (B) Absorbance 
at 280 nm of hPrx3 in 20 mM Tris, 150 mM NaCl, 10 mM DTT, pH 9.0. 
Under both conditions there is evidence of aggregation occurring in the 10 mg/ml samples, 
as peaks are not clearly defined and have broad shoulders. However, peaks were visible 
that corresponded to approximately 35 kDa, which would indicate that the dimeric form of the 
protein is favoured. 
Higher pH favours the dimeric species, even in the presence of reductant. This may be due 
to the disruption of hydrogen bonds with in the A-type interface (1.7.2). 
Samples were also examined at reduced pH, as the interface also contains His residues 
which, near pH 6.0, can become protonated and positively charged. The introduction of a 
charge in the interface could be disruptive to higher order species formation. At low pH, 
TCEP was used as the reductant instead of DTT as DTT is not able to act as a reductant 
below pH 7. 
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Figure 2.8: (A) Absorbance at 280 nm of hPrx3 in 20 mM NaPi, 150 mM NaCl, pH 6.0. (B) 
Absorbance at 280 nm of hPrx3 in 20 mM NaPi, 150 mM NaCl, 10 mM TCEP, pH 6.0. 
In lowered pH, three peaks are visible. The first corresponds to a species with an 
approximate molecular mass of 390 kDa, while the second corresponds to a species with an 
approximate molecular mass of 50 kDa. 
The third peak is near the column cutoff volume of 24 ml. The identity of this species is not 
clear, it is too small to be a protein, and is most likely a small molecule. 
In the presence of reductant at pH 6.0, a high level of aggregation was apparent, with the 
protein visibly dropping out of solution at 10 mg/ml. For this reason, no data was collected 
for protein under these conditions. The peaks present correspond to species with molecular 
weights of approximately 40 kDa, indicating that the dimeric form may be favoured under 
these conditions. 
Both pH 6.0 conditions show an increase in dimeric species compared to the protein in NaPi 
at pH 7.5 (Figure 2.6). This may be due to the protonation of a His residue present in the A-
type interface, H76. Protonation of this residue would introduce a positive charge into the 
interface, which would destabilise assembly using this interface. 
Across the samples examined, two main species are observed. The first is a high molecular 
mass species that is favoured by increased concentration, reductant and NaPi buffer. It is 
likely that this represents a ring shaped species, either a decamer or a dodecamer. It is not 
possible to accurately between these species using this technique, as their shapes means 
the elution volume observed will not correlate accurately with their molecular mass. 
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The second species observed has a low molecular mass, and is favoured in lower 
concentrations and at pH higher and lower than 7.5. This is likely the dimeric form of hPrx3. 
The more globular shape of the dimeric form of hPrx3 means that the values calculated for 
this species will be more accurate than for ring shaped species. The smaller species 
observed in wild type hPrx3 correspond to species with molecular masses of approximately 
40 kDa, consistent with them being the dimer form of hPrx3. 
2.2.2 SAXS analysis of wild type hPrx3 
Small angle X-ray scattering (SAXS) is a powerful tool for investigating the three dimensional 
shape of proteins in solution. Samples are exposed to an X-ray beam, which is scattered by 
any particles present in the solution. The intensity of scattered X-rays and the angle at which 
they scatter yields information about the shape of the species that gave rise to them. As 
particles in solution have little long range order, accurate information can only be gained up 
to the nanometre range. Although SAXS cannot show the structure of a protein to atomic 
precision as X-ray crystallography can, it allows protein to be examined in solution and at 
relatively low concentrations, making it useful to compare to other experiments carried out in 
similar conditions (Mertens and Svergun 2010). 
SAXS data can be analysed by various programs to derive the radius of gyration from the 
scattering data, and the molecular weight and dimensions of the species that produced the 
scattering pattern can be estimated (Konarev et al. 2006; Petoukhov et al. 2012).  
 As described in 6.5, SAXS data from hPrx3 was collected and analysed. SAXS 
measurement requires a homogenous sample to acquire useful data; as if multiple species 
are present, observed scattering will be derived from both species. Thus, samples were 
separated through a 3 ml gel filtration column before entering the X-ray beam. Scattering 
was collected from samples in 20 mM Tris, 150 mM NaCl at pH 7.5, as protein was known to 
be stable in these conditions, and contained a mixture of dimers and higher ordered species. 
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Figure 2.9: Contour graph showing the intensity of SAXS images of wild type hPrx3 collected after 
separation of species by gel filtration. Blue shows low intensity, while yellow shows high intensity. 
Image No. is the number of the scattering image used and is equivalent to the elution volume, while q 
is the scattering angle. 
For the wild type enzyme, two species were detected. Images corresponding to each of 
these were averaged using the program Scatterbrain and used to calculate the properties of 
that species. For the first peak, frames 291-300 were used; for the second peak, frames 
372-380 were used. Data collected were analysed using the program PRIMUS from the 
ATSAS package (Konarev et al. 2006).  
Data corresponding to the two species observed were analysed in several ways. Guinier 
analysis was used to estimate the radius of gyration and evaluate the quality of the data by 
identifying if attractive interparticle effects were present (Mertens and Svergun 2010). The 
AutoPorod function of PRIMUS was used to calculate the Porod volume from the Guinier 
region of the data. This is used to estimate the maximum dimensions and molecular mass of 
the species present, as Porod volume is correlated to the molecular mass (Petoukhov et al. 
2012).  
GNOM analysis was used to calculate the distance distribution function, p(r). This gives an 
indication of the particle shape, as it shows the distribution of distances between points 
within the particle. It also gives a more accurate calculation of the radius of gyration than 
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Guinier analysis, as it uses all the scattering data rather than only the linear region (Mertens 
and Svergun 2010). 
The program CRYSOL was used to compare the scattering observed to theoretical 
scattering calculated from the crystal structure of bovine Prx3 (PDB code 1 ZYE (Cao et al. 
2005)). CRYSOL also calculated the theoretical radius of gyration of the crystal structure 
(Svergun, Barberato, and Koch 1995). 
The results of these analyses are summarised in Table 1.  
 Guinier GNOM AutoPorod 
 Rg Error Rg Error DMAX MW 
Peak 1 60.5 ±1.39 60.29 ±0.98 188 293 
Peak 2 42.7 ±1.58 43.98 ±0.33 78 53.3 
 
Table 2.1: Analysis of SAXS data for wild type hPrx3. Data analysis was carried out using the 
programs Scatterbrain and PRIMUS. Rg is radius of gyration in Å, Error is the standard error in the 
radius of gyration in Å, DMAX is the maximum dimensions of the species in Å and MW is the molecular 
weight in kDa. Peak 1 is made from images 291-300, Peak 2 is made from images 372-380. 
For peak 1, analysis of the data shows the presence of a species with a radius of gyration of 
approximately 60 Å. AutoPorod indicates a species with a molecular weight of 293 kDa, 
which would correspond to a species made up of 13.3 monomers of 22 kDa, suggesting that 
the protein may be dodecameric in structure. The calculated molecular weight means that 
the Porod volume is approximately 451 nm3, as molecular mass is approximately 0.65 times 
the Porod volume. The DMAX value of 188 Å is close to the maximum dimension of the crystal 
structure of dodecameric bovine peroxiredoxin, which is 150 Å. 
Examination of the p(r) plot (Figure 2.10A) for peak 1 is consistent with the protein being 
present as a ring shaped species. There are fewer medium distances within the particle than 
short or long distances, consistent with a space in the centre of the particle. 
CRYSOL was used to align the observed data of peak 1 with the theoretical scattering of 
bovine Prx3 from the crystal structure (Figure 2.10B). This showed a strong alignment, with 
a Chi-squared value of 0.930. This is strong evidence for the species observed being 
dodecameric in structure. CRYSOL also produced calculated radius of gyration and volume 
calculations from the crystal structure. The calculated radius of gyration was 54.58 Å, while 
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the calculated volume was 441 nm3. This is close to that seen in peak 1. The radius of 
gyration calculated is somewhat smaller than that of the observed species, this is likely due 
to the fact that the crystal structure 1ZYE (Cao et al. 2005) does not include the last 32 
amino acid residues of the protein sequence. 
 
Figure 2.10: (A) p(r) plot of peak 1. Error bars are shown in black. (B) CRYSOL alignment of 
observed scattering of wild type hPrx3 peak 1 (black) and calculated scattering of dodecameric 
bovine Prx3. Chi-squared of the fit is 0.930. Log(I) is the log of the intensity of scattering observed, 
and s is the scattering angle in Å. Calculated scattering curves were generated from the PDB 
structure 1ZYE (Cao et al. 2005). 
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For peak 2, analysis of the data showed a species with a radius of gyration of approximately 
43 Å. Guinier analysis showed evidence of self-association. Although this makes the data 
collected less reliable, it was expected as the dimer shows assembly to form the higher 
order species observed. AutoPorod indicates a species with a molecular weight of 53.3 kDa, 
which corresponds to 2.4 monomers of 22.0 kDa, suggesting that the species observed is 
dimeric. It also shows a Porod volume of approximately 120 nm3. The DMAX value of 78 Å is 
consistent with the species being a dimer, as the crystal structure of dimeric bovine 
peroxiredoxin shows a maximum dimension of approximately 67 Å. 
Examination of the p(r) plot for peak 2 is consistent with the species being a dimeric 
peroxiredoxin (Figure 2.11A). Most distances are short, but a few longer, indicating an 
elongated structure. 
The scattering observed in peak 2 aligned quite well with the calculated scattering of the 
dimeric form of bovine Prx3, with a Chi-squared value of 1.10 (Figure 2.11B). The observed 
data diverges at small angles, likely due to the self-association observed in the sample. The 
calculated radius of gyration of the dimer from the crystal structure is 20.3 Å, significantly 
smaller than what was observed for peak 2. The calculated volume was 50 nm3, again much 
smaller than what was observed for peak 2. This may be due to the inaccuracies caused by 
the self-association of the species, or due to the species having a significantly different 
structure than seen in the crystal structure. 
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Figure 2.11: (A) p(r) plot of peak 2. Error bars are shown in black. (B) CRYSOL alignment of 
observed scattering of wild type hPrx3 peak 1 (black) and calculated scattering of dimeric bovine 
Prx3. Chi-squared of the fit is 1.10. Log(I) is the log of the intensity of scattering observed, and s is the 
scattering angle in Å. Calculated scattering curves were generated from the PDB structure 1ZYE (Cao 
et al. 2005). 
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2.2.3 TEM of wild type hPrx3 
Electron microscopy provides the ability to directly observe the protein, allowing the accurate 
measurement of higher order structures, as well as the ability to observe species that may 
not be present in significant qualities to accurately characterise using other techniques. 
As described in 6.3, samples of wild type hPrx3 were analysed by TEM after negative 
staining in order to directly image the species observed in SEC (2.2.1) and SAXS (2.2.2) and 
confirm that the higher order species were ring shaped dodecamers. Images were produced 
using a Morgagni 268D TEM, measuring at 100 kV by Dr Celine Valery. Images were 
captured images using a SIS/Olympus Megapixel III digital camera. 
The TEM image clearly shows the presence of ring shaped structures in the sample. These 
structures have average external diameters of 140 Å and internal diameters of average 70 Å. 
This matches very closely to the size seen in the crystal structure of dodecameric bovine 
peroxiredoxin 3 (Cao et al. 2005), which shows a maximum external diameter of 
approximately 145 Å and an interior diameter of 70 Å. 
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Figure 2.12: (A) Wild type hPrx3 at a concentration of 10 mg/ml in 20 mM Tris, 150 mM NaCl, 10 mM 
EDTA, pH 7.5. Samples are negatively stained using 1% Uranyl acetate.  (B) Magnified view showing 
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2.3 Analysis of the quaternary structure of hPrx3 S78A 
An hPrx3 mutant was designed, hPrx3 S78A. This contains a residue substitution in the A-
type interface, the interface used in building ring shaped structures. PISA analysis showed 
that S78 is likely to form a hydrogen bond across the interface, and previous research has 
indicated that a similar mutation in a bacterial peroxiredoxin favours assembly (Parsonage et 
al. 2005). 
2.3.1 SEC Analysis of S78A mutant hPrx3 
hPrx3 S78A was examined using SEC in the same conditions as the wild type enzyme 
(2.2.1). This protein has a calculated molecular mass of while the decameric form is 220.3 
kDa and the dodecameric form is 264.3 kDa.  
        
 
Figure 2.13: (A) Absorbance at 280 nm of S78A hPrx3 in 20 mM Tris, 150 mM NaCl, pH 7.5. (B) 
Absorbance at 280 nm of S78A hPrx3 in 20 mM Tris, 150 mM NaCl, 10 mM DTT, pH 7.5. 
In the non-reduced sample, two main peaks can be seen. These correspond to species of 
approximately 390 kDa and 40 kDa. The proportions of species are different than that seen 
in the wild type enzyme, with more protein being seen in the higher order form, even at low 
concentrations.  
In the reduced sample only one peak is visible, which corresponds to a species with an 
approximate molecular mass of 380 kDa. 
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Figure 2.14: (A) Absorbance at 280 nm of S78A hPrx3 in 20 mM NaPi, 150 mM NaCl, pH 7.5. (B) 
Absorbance at 280 nm of S78A hPrx3 in 20 mM NaPi, 150 mM NaCl, 10 mM DTT, pH 7.5. 
In the non-reduced sample, two peaks can be seen, a large peak corresponding to a higher 
order species of approximately 400 kDa, and a very small peak corresponding to 
approximately 50 kDa. Compared to the wild type in these conditions, hPrx3 S78A shows an 
increased proportion of the larger species, and a lower proportion of the smaller species. 
In the reduced sample, only one peak can be seen, corresponding to the higher order 
species and having a molecular weight of approximately 380kDa. No evidence of any 
smaller species can be seen under these conditions, indicating that the higher order species, 
most likely a dodecamer, is very strongly favoured. 
It was intended to analyse hPrx3 S78A at pH 9.0 in the presence and absence of reductant, 
however insufficient time was available to do so. 
At pH 6.0, protein showed extensive aggregation, do no size exclusion analysis was carried 
out for protein under these conditions.  
The species observed in hPrx3 S78A have similar masses to those seen in wild-type hPrx3 
and are most likely the same forms of the protein, with the larger species being a ring 
shaped dodecamer, and the smaller being a dimer. This is as expected, as the mutant has a 
very similar molecular mass to the wild type. However, differences in proportions are 
apparent. hPrx3 S78A shows higher proportions of the larger species, consistent with the 
research carried out in the bacterial peroxiredoxin (Parsonage et al. 2005). The likely cause 
of this is that the serine residue formed a hydrogen bond to the solution in the wild type, and 
removing this removed an interaction favouring the dimeric form. As the mutation did not 
introduce any bulky or charged groups that could disrupt dodecamer formation, dodecamer 
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was favoured. There would also be a gain in stability for the dodecameric form due to the 
burial of the hydrophobic methyl group in the interface. 
2.4 Analysis of the quaternary structure of His-tagged hPrx3 
His-tagged hPrx3 was also purified and examined, to investigate whether the presence of N-
terminal His-tags affected assembly, and whether this was linked to their metal ion binding 
abilities. 
2.4.1 SEC Analysis of His-tagged hPrx3 
His-tagged hPrx3 was examined using SEC in the same conditions as wild type hPrx3 
(2.2.1). Calculation from the amino acid sequence gives a theoretical molecular mass of 50.4 
kDa for the tagged dimer, 252.0 kDa for a decamer and 302.3 kDa for a dodecamer. 
        
 
Figure  2.15: (A) Absorbance at 280 nm of His-tagged hPrx3 in 20 mM Tris, 150 mM NaCl, pH 7.5. 
(B) Absorbance at 280 nm of tagged hPrx3 in 20 mM Tris, 150 mM NaCl, 10 mM DTT, pH 7.5. 
In non-reduced conditions, two peaks were observed. The first is very large and represents a 
species with an approximate molecular mass of 770 kDa, while the second peak shows a 
much smaller signal, and corresponds to a species with a molecular mass of 50 kDa. 
Compared to wild type hPrx3, a much higher proportion of the protein is present as large 
structures, indicating that the presence of His-tags strongly favour the formation of larger 
structures in these conditions. The size of the larger species is also much larger than what 
was seen in wild type hPrx. This may be due to the protein favouring a species even larger 
than a ring shaped dodecamer, such as a stack of multiple rings. 
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In reduced conditions, two peaks can be seen, with a higher proportion of the protein being 
present in the first peak. The peaks correspond to molecular mass of 650 kDa, while the 
smaller corresponded to 50 kDa.  
Compared to the wild type enzyme, both conditions favour higher order species strongly, 
with almost no dimeric protein present.  
        
  
Figure 2.16: (A) Absorbance at 280 nm of tagged hPrx3 in 20 mM NaPi, 150 mM NaCl, pH 7.5. (B) 
Absorbance at 280 nm of tagged hPrx3 in 20 mM NaPi, 150 mM NaCl, 10 mM DTT, pH 7.5. 
In the non-reduced sample, two peaks are again visible, with the majority of the protein 
being in higher order species with a molecular weight corresponding to approximately 670 
kDa. The smaller peak corresponds to a molecular weight of approximately 50 kDa. 
In the reduced sample, only one peak is present, with a molecular weight corresponding to 
approximately 750 kDa. Under these conditions, all protein is present in higher order 
species, even the lowest concentration measured. 
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Figure 2.17: (A) Absorbance at 280 nm of tagged hPrx3 in 20 mM Tris, 150 mM NaCl, pH 9.0. (B) 
Absorbance at 280 nm of tagged hPrx3 in 20 mM Tris, 150 mM NaCl, 10 mM DTT, pH 9.0. 
At elevated pH, two main peaks are visible, with the majority of protein in the higher order 
peak. These peaks correspond to species with approximate molecular weights of 780 kDa 
and 85 kDa. While the larger species has a similar estimated weight to the samples 
examined at pH 7.5, the smaller species seems too large for a dimeric protein. Its size 
makes a trimeric or tetrameric form seem more likely. A much higher proportion of the 
protein is present as the smaller species compared to His-tagged hPrx3 seen at neutral pH. 
In reduced conditions, one main peak was visible. This corresponded to a molecular weight 
of approximately 395 kDa. In the 1 mg/ml trace, a second peak is also present, which 
corresponds to a molecular mass of approximately 40 kDa.  
At pH 6.0, protein showed extensive aggregation, so no SEC analysis was carried out at this 
pH. The likely cause of this is that this is close to the isoelectric point of the protein, which 
was calculated to be pH 5.97 using the compute MW/pI tool from ExPASY 
(http://web.expasy.org/compute_pi/). 
In the conditions examined, His-tagged hPrx3 showed two main species present. The larger 
species showed a wide variation in its mass, but tended to be larger than 650 kDa. The 
variation may be due to small errors in calibration, as in peaks close to the void volume such 
as these, small differences in elution volume can correspond to large changes in calculated 
mass. However, the data does indicate that very large species are present. It is not possible 
to accurately estimate whether they correspond to decamers, dodecamers or even larger 
higher order species. The smaller species seen, however, was generally calculated to have 
a mass near 50 kDa, consistent with it being the dimeric form of His-tagged hPrx3. 
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2.4.2 SAXS analysis of His-tagged hPrx3 
SAXS data was collected from His-tagged hPrx3 to examine the size and shape of the 
species present.  
 
Figure 2.18: Contour graph intensity of SAXS images of His-tagged hPrx3 collected after separation 
of species by gel filtration. Blue shows low intensity, while yellow shows high intensity. Image No. is 
the number of the scattering image used and is equivalent to the elution volume, while q is the 
scattering angle. 
Two peaks were observed for the His-tagged hPrx3  sample, however, the second did not 
provide enough useful data for analysis. The presence of two peaks, one corresponding to a 
much higher proportion of the protein in the sample, is consistent with the results of SEC 
(2.2.3).  Images corresponding to the first peak (289-295) were averaged and used for 
analysis as in (2.3.1). The results are summarised in Table 2. 
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 Guinier GNOM AutoPorod 
 Rg Error Rg Error DMAX MW 
Peak 1 60.8 ±0.55 63.27 ±0.78 212 424 
 
Table 2: Analysis of SAXS data for His-tagged hPrx3. Peak 1 is made from frames 289-295. Data 
analysis was carried out using the programs Scatterbrain and PRIMUS. Rg is radius of gyration in Å, 
Error is the standard error in the radius of gyration in Å, DMAX is the maximum dimensions of the 
species in Å and MW is the molecular weight in kDa. 
Analysis of the data shows the presence of a species with a radius of gyration of 
approximately 62 Å. AutoPorod indicates a species with a molecular weight of 424 kDa, 
which would correspond to a species made up of 16.8 monomers of 25.2 kDa. The 
calculated molecular weight means the Porod volume is approximately 650 nm3. The DMAX 
value is 212 Å.  
This data indicates that the overall size of the species observed is only slightly larger than 
the wild type hPrx3, however, the volume is significantly larger. This may indicate that the 
species observed is an assembly of multiple rings, such as a stack or a catenane. 
Examination of the p(r) plot (Figure 2.19A) confirms that the structure is very different than 
that of wild type hPrx3. The distances seen are consistent with an ellipsoid or oblate 
structure (Mertens and Svergun 2010). 
CRYSOL alignment of the observed data with theoretical scattering calculated from the 
bovine Prx3 also showed that the structure was very different from that of wild type hPrx3, as 
it did not closely match the calculated data, showing a Chi-squared value of 4.44 (Figure 
2.19B). When compared to the catenane form, a slightly lower Chi-square value or 2.35 is 
seen (Figure 2.20). This may indicate that His-tagged hPrx3 is in a higher order form. It is 
not expected that the observed data match very closely with calculated data from the crystal 
structure, as His-tagged hPrx3 contains both the C-terminal region not present in the crystal 
structure and the additional His-tag, which increases the molecular mass per monomer by 
8.5 kDa. 
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Figure 2.19: (A) p(r) plot of peak 1. Error bars are shown in black. (B) CRYSOL alignment of 
observed scattering of His-tagged hPrx3 peak 1 (black) and calculated scattering of dodecameric 
bovine Prx3. Chi-squared of the fit is 4.44. Log(I) is the log of the intensity of scattering observed, and 
s is the scattering angle in Å. Calculated scattering curves were generated from the PDB structure 
1ZYE (Cao et al. 2005). 
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Figure 2.20: CRYSOL alignment of observed scattering of His-tagged hPrx3 peak 1 (black) and 
calculated scattering of bovine Prx3 catenane. Chi-squared of the fit is 2.35. Log(I) is the log of the 
intensity of scattering observed, and s is the scattering angle in Å. Calculated scattering curves were 
generated from the PDB structure 1ZYE (Cao et al. 2005). 
 
2.4.3 TEM of His-tagged Prx3 
As described in 6.3 TEM was used to investigate the structure of the higher order species 
observed by SEC (2.4.1), and to see if the shape of the species observed in SAXS (2.4.2) 
represented a higher order species. Images were produced Morgagni 268D TEM, measuring 
at 100 kV by Dr Celine Valery Images were captured using a SIS/Olympus Megapixel III 
digital camera. 
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Figure 2.21: (A) His-tagged hPrx3 at a concentration of 10 mg/ml in 20 mM Tris, 150 mM NaCl, 10 
mM EDTA, pH 7.5. Samples are negatively stained using 1% Uranyl acetate.  (B) Magnified view 
showing rings. 
The TEM image shows ring shaped species similar to those seen in wild type hPrx3 (2.2.3). 
These rings have an average external diameter of 140 Å, and an average internal diameter 
of 70 Å, the same as seen in the wild type enzyme. This indicates that the protein is most 
likely a dodecamer. 
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2.4.4 Effects of EDTA on His-tagged hPrx3 
As the His-tag binds metal ions very tightly, the addition of metal ions was investigated to 
see whether this would alter the equilibrium between oligomeric states of the tagged protein. 
However, it was found that addition of nickel ions at concentrations as low as 1 mM caused 
rapid aggregation of protein. This aggregate was analysed by TEM (6.2), to observe any 
very high order species present. Images were produced Morgagni 268D TEM, measuring at 
100 kV by Dr Celine Valery Images were captured using a SIS/Olympus Megapixel III digital 
camera. 
 
Figure 2.22: Tagged hPrx 3 at a concentration of 10 mg/ml in 20 mM Tris, 150 mM NaCl, 10 mM 
NiCl2, pH 7.5. 
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Figure 2.23  (B) Magnified view of the rings seen in Figure 2.22 showing rings. (C) Magnified view 
showing three stacked rings. 
The TEM images revealed the presence of both ring and stack shaped formations. Rings 
had an average external diameter of approximately 140 Å, and an average interior diameter 
of approximately 46 Å, significantly less than that seen in the wild-type enzyme and the His-
tagged wild type in the absence of nickel. A possible cause for this is that the N-terminus of 
the protein is on the inside face of the dodecamer, so His tags could project towards the 
centre of the ring. The presence of nickel could allow them to become ordered enough to be 
visible in the TEM image. 
The stack of rings in Figure 2.22B is approximately 135 Å long, which corresponds to three 
rings stacked end to end, as each ring is approximately 45 Å tall in the crystal structure of 
bovine Prx3. The width of the stack is also consistent with the width of tagged hPrx3 rings. A 
structure such as this may be the identity of the species observed in the SAXS data (2.42).  
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Tagged protein was also analysed in the presence of the chelating agent EDTA to test 
whether metal ion binding played a role in the differences seen in the quaternary structure 
properties of His-tagged hPrx compared to wild type hPrx3. 
        
 
Figure 2.24: (A) Absorbance at 280 nm of His-tagged hPrx3 in 20 mM Tris, 150 mM NaCl, 10 mM 
EDTA, pH 7.5. (B) Absorbance at 280 nm of His-tagged hPrx3 in 20 mM Tris, 150 mM NaCl, pH 7.5. 
With the addition of EDTA, two peaks are visible, corresponding to species with molecular 
weights of 720 kDa and 48 kDa. These are similar to the sizes seen for the protein in the 
absence of EDTA, shown in Figure 2.22 B. However, the proportions are different, with more 
protein being present in the dimeric form. This indicates that metal binding has an important 
role in the altered oligomeric properties of tagged hPrx3. The proportions do not match those 
seen for the wild type protein, which indicates that either metal binding does not account for 
all the differences between wild type and His-tagged hPrx3, or that EDTA is not able to 
completely remove all metal ions from the His-tagged protein. It also indicates that metal 
ions are present in His-tagged samples examined in (2.4.1) and (2.4.3). The origin of these 
ions may either be the metal affinity column used in purification of the enzyme, or the 
bacteria in which they were synthesised (6.2). 
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2.5 His-tagged hPrx3 S78A 
As mentioned previously, His-tagged S78A showed poor solubility, and formed cloudy 
aggregates in solution. These aggregates were investigated using TEM to observe whether 
any higher order species were present. 
 
Figure 2.25: (A) His-tagged hPrx3 S78A at a concentration of 3 mg/ml in 20 mM Tris, 150 mM NaCl, 
10 mM NiCl, pH 7.5. 
TEM showed the presence of unordered aggregates and no evidence of ordered species. 
This indicates that aggregation was due to protein instability in these conditions, as opposed 
to the aggregation observed in His-tagged hPrx3 upon the addition of nickel ions (2.4.3). 
Chapter Two: Results and Discussion (hPrx3)  56 
 
2.6 Preliminary comparison of activity of hPrx3 variants 
It has previously been reported that mutations affecting the quaternary structure of 
peroxiredoxins alter their activity (Parsonage et al. 2005). As the hPrx3 variants produced 
showed different oligomeric properties, their activity was measured to investigate whether 
their altered quaternary structure resulted in differing enzyme activity. 
2.5.1 Activity assay for wild type hPrx3 
An activity assay based on that described in (Ogusucu et al. 2007) was used to examine 
whether the different forms of hPrx3 had different levels of enzymatic activity. This assay 
was based on competition with horseradish peroxidase, an enzyme that degrades hydrogen 
peroxide with a known rate (Dolman et al. 1975). This enzyme contains a heme group with a 
distinctive absorbance. When reacting with hydrogen peroxide, this absorbance is lost. By 
comparing the change in absorbance of this enzyme in the presence of hydrogen peroxide 
and differing concentrations of peroxiredoxins to the absorbance of HRP in the absence of 
these reactants, the rate of reaction of the peroxiredoxin can be calculated (Nelson et al. 
2008). 
The kcat/kM of the enzyme can be calculated from the slope of a graph comparing the 
concentration of the peroxiredoxin enzyme used and the term (F/F-1)kHRP[HRP]. In this term: 
(F/1-F) is a ratio derived from the absorbance of the HRP heme with H2O2 present, its 
absorbance with H2O2 and hPrx3 present and its absorbance with neither reactant present 
kHRP is the kcat/kM of HRP in M
-1s-1 
[HRP] is the concentration of HRP 
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Figure 2.26: Results of the activity assay for wild type hPrx3. As preparation of samples produced a 
limited amount of protein to carry out assays, each point represents a single measurement. 
The trend line of the graph for the activity assay of wild type hPrx3 gives a kcat/kM value of 
2.0 ×107 M-1s-1. The trend line fits quite well to the data, with an R2 value of 0.93. The 
calculated value of kcat/kM is close to the reported value for another peroxiredoxin enzyme, 
Salmonella typhimurium AhpC, which has a kcat/kM of 3.7×10
7 (Parsonage et al. 2005), as 
well as to the results reported in other uses of this assay (Ogusucu et al. 2007; Nelson et al. 
2008). 
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2.5.2 Activity assay for hPrx3 S78A 
 
Figure 2.27: Results of the activity assay for S78A hPrx3. 
The trend line of the graph for the activity assay of S78A hPrx3 gives a kcat/kM value of 4.3 
×107 M-1s-1. Again, this is of the same order of magnitude as previously reported 
peroxiredoxin enzymes. The value is approximately twice that of the wild type enzyme, 
suggesting that this mutant reacts with H2O2 faster than the wild type enzyme. However, 
more replicates would be needed to confirm this, as the trend line does not fit as well to the 
data as that of the wild type enzyme, with an R2 of 0.84. 
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2.5.3 Activity assay for His-tagged hPrx3 
 
 
Figure 2.28: Results of the activity assay for tagged hPrx3. 
The trend line of the graph for the activity assay of tagged hPrx3 gives a kcat/kM value of 5.7 
×107 M-1s-1. This is again close to previously calculated peroxiredoxin kcat/kM values, and is 
also larger than the value for the wild type enzyme, indicating faster reaction with H2O2. 
However, the data does not fit to a line as well as that of the other protein variants, showing 
a distinct step between 2 and 4 µM, and an R2 value of 0.82. This was seen over multiple 
replicates at this concentration. A possible cause for this is a shift in oligomeric state near 
this concentration. As the lowest concentration of tagged protein examined using SEC was 1 
mg/ml, which is approximately 40 µM, further experiments would be necessary to 
investigate. 
Activity measurements showed that all three enzyme variants had peroxide reducing activity 
and were able to compete with HRP. They also suggested that the variants that promoted 
the formation of higher order species had higher levels of activity than the wild type. 
However, more extensive experiments would be required to confirm this, as error in activity 
measurement is likely to be large. 
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2.6 Summary of Results 
Three forms of hPrx3 were successfully purified: wild type hPrx3, hPrx3 S78A and His-
tagged hPrx3. His-tagged hPrx3 S78A proved unstable in the buffers used during 
purification. 
SEC analysis of these protein showed that each variant exhibited a different ratio of smaller 
and larger structures. Self-assembly in hPrx3 was shown to be complex, and influenced by 
protein concentration, pH and buffer as well as redox state. The size of the smaller species 
observed indicated it was a dimer, but the larger species did not correlate well in size to 
decameric or dodecameric species, likely due to their non-globular shape. TEM and SAXS 
indicated that these species were ring shaped, dodecameric species. 
Both hPrx3 S78A and His-tagged hPrx3 showed increased proportions of higher order 
species compared to wild type hPrx3 across all conditions examined. In S78A, the large 
species showed a similar relationship between the calculated molecular weight of the dimer 
and that of the larger species as that seen in the wild type protein. This indicated that the 
larger species was likely to also be a ring shaped dodecamer. 
His-tagged hPrx3 showed a very pronounced preference for self-assembly, with the protein 
being almost entirely present as larger species, even in the absence of reductant. The 
identity of the larger species was not clear, as TEM images indicated a dodecameric ring 
shaped species, but SAXS scattering indicated a larger species.  
The increased proportions of larger species seen in His-tagged hPrx3 was found to be 
partially due to metal ion binding, as addition of EDTA decreased the proportion of large 
species seen, while the addition of nickel ions caused the protein to rapidly become 
insoluble. TEM analysis of the insoluble protein revealed it to be formed from dodecameric, 
ring shaped structures and even short stacks of rings. 
Preliminary activity assays showed that all variants analysed had activity of similar levels to 
that seen in other peroxiredoxins, and suggested that the variants that favoured self-
assembly had higher activity than wild type hPrx3. However, further investigation is 
necessary to confirm this. 
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CHAPTER THREE 
Results and Discussion (TaqPrx) 
 
Peroxiredoxins have the ability to self-assemble to form higher order species from smaller 
building blocks. This is controlled by the environment of the protein and its structure. A 
thermophilic peroxiredoxin demonstrating self assembly would be expected to have a very 
stable A-type interface in order to form higher order species at elevated temperatures. 
Higher heat tolerance would be a useful property for any nanodevice based on a 
peroxiredoxin system. However, no higher order structure forming thermophilic 
peroxiredoxins from the AhpC-Prx1 class (1.6.1) have been characterised. For this reason, it 
was an attempt was made to purify and characterise such a protein.  
3.1 Sequence comparisons of hPrx3 and thermophilic 
peroxiredoxins 
3.1.1 Clustal Omega alignment of peroxiredoxins 
The peroxiredoxin genes of several thermophilic organisms were examined in order to 
determine their similarity to hPrx3 and their suitability for investigation of their quaternary 
structure. Peroxiredoxin genes for the archaean species Pyrococcus furiosus, Pyrobaculum 
aerophilum, Sulfolobus acidocaldarius and Ignisphaera aggregans, and the bacterial species 
Thermotoga maritima and T. aquaticus were compared using Clustal Omega 
(www.ebi.ac.uk/Tools/msa/clustalo/) (Sievers et al. 2011) (Figure 1). These organisms were 
selected as their genomic DNA was easily obtainable from other laboratories. Clustal Omega 
quickly aligns multiple sequences and has been demonstrated to have a high degree of 
accuracy (Sievers et al. 2011). No information other than the amino acid sequence was used 
to make the alignment. 
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H. sapiens      1 ----APAV-TQHAPYFKGTAVVNGEFKDLSLDDF--KGK-YLVLFFYPLDFTFVCPTEIVAFS 56 
I. aggregans   1 MVGQIPLI-GEKFPE-MTV--VTTHGVKKLPDDY--KGK-WLVLFSHPADFTPVCTTEFYAFA 56 
P. aerophilum   1 ----------MKIPEDLCF--NTDHGPKCFK-DY--KGK-WLLLFSHPADFTPVCTTEFVAFS 47 
P. furiosus   1 ----MIVI-GEKFPE-VEV--KTTHGVIKLPDHFTKQGK-WFMLFSHPADFTPVCTTEFYGLQ 55 
S. acidocaldarius    1 ----MALEKGNEAPD---FEGDSTIGKL-KLSSY--RGKSVVVLYFYPKAFTPGCTRETIKFG 53 
T. maritima    1 MEGRIPLI-GEEFPR-VEV--KTTHGKKVLPDDF--RGK-WFVLFSHPADFTPVCTTEFVAFQ 57 
T. aquaticus*        1 ----MSLV-GKKVQPFRAQAYHNGEFIEVTEQDF--MGK-WSIVCFYPADFTFVCPTELEDLQ 56 
T. aquaticus   1 ----MPGMEGTLAPD---FALPDQEGRVHRLSDY--RGR-WVVLYFYPKDDTPGCTKEACGFR 54 
 
 
H. sapiens  57 DKANEFHDVNCEVVAVSVDSHFSHLAWINTPRKNGGLGHMNIALLSDLTKQISRDYGVLLE-G 118 
I. aggregans   57 KRYNDFKELNTELLGHSVDSVYSHIKWIEWIKEKLGI-EIPFPIIADPTGDVARKLGFLHAQS 118 
P. aerophilum   48 RKYEEFKKRGVELLGLSVDTNYSHIEWKRQIEQAFGV-KVPFPIIADVDMKVASIFNAVPP-G 108 
P. furiosus   56 IRLEKFRELGVEPIGLSVDQVFSHLKWMEWIKEKLGV-EIEFPVIADDRGDLAEKLGMIPS-G 116 
S. acidocaldarius   54 QLYDQFKQLNAEVIGVSVDTVSTQKSFADKC-------GARFPIVSDSNKQIAKLYGVLNEKG 110 
T. maritima   58 KRYDEFRKLNTELIGLSIDQVFSHIKWIEWIKEKLGV-EIEFPVIADDLGEVSRRLGLIHPNK 119 
T. aquaticus*  57 DHYATFKELGVEVYSVSTDTHYTHKAWHDTSPA---ISKIEYVMIGDPSHQLSRMFDVLDE-E 115 
T. aquaticus  55 DRMGDLQALGAVVLGVSADDVASHKRFAEKY-------GLNFPLLADPERQAILAYGAWGKKN 110 
 
 
H. sapiens    119 S-----GLALRGLFIIDPNGVIKHLSVNDLPVGRSVEETLRLVKAFQYVET-HGEVCPANWTP 175 
I. aggregans 119 A-----SHTVRAVFIVDPDGIIRAILYYPQEVGRNIDEILRLLKALQVNTQ-YKVALPANWPN 175 
P. aerophilum  109 Q-----NLTVRTVALIDPDLKLAWFAAYPYTNGRNIDEILRVIDAIQFSYK-YGYATPADWKP 165 
P. furiosus  117 S-----TITARAVFIVDDKGIIRAIVYYPAEVGRDWDEILRLVKALKISTE-KGVALPHKWPN 173 
S. acidocaldarius  111 S------SAQRVTFIIDENGKIIEVLSGLGNAEEHANKSLEIIKRIRGKT------------- 154 
T. maritima  120 G-----TNTVRAVFIVDPNGIIRAIVYYPQEVGRNIDEILRAVKALQTSDE-KGVAIPANWPS 176 
T. aquaticus*     116 Q-----GLAQRGTFIIDPDGVIQAVEINADGIGRNASTLIDKIKAAQYVRNHPGEVCPAKWKE 173 
T. aquaticus 111 LYGKEYEGVLRQTFLIDPEGRIAKVWRKVSP-EGHAEEVAEALRQARGE-------------- 157 
 
 
 
H. sapiens 176 ----DSPTIKPSPAASKEYFQKVNQ------------------------------------ 196 
I. aggregans 176 NELIGQNAIVPPASNVIDAAERL-----KQYKCYDWWFCYKEIPEQEAERARAFLKRVAGL 233 
P. aerophilum 166 ----GDPVIVPPPPTTEGAA----------------------------------------- 181 
P. furiosus 174 NELIGDKVIVPPASSVEQIKEREEAKAKGEIECYDWWFCYKKLE----------------- 220 
S. acidocaldarius 155 ------------------------------------------------------------- 155 
T. maritima 177 NELINDSVIVPPASSVEEARKRLES---KDFECYDWWFCYKKV------------------ 217 
T. aquaticus* 174 ----GAETLKPSLDLVGKI------------------------------------------ 188 
T. aquaticus 160 ------------------------------------------------------------- 160 
 
Figure 3.1: Clustal Omega alignment of multiple thermophilic peroxiredoxins and hPrx3. The 
peroxiredoxin motif (PXXXTXXC) is highlighted in yellow, the overoxidation motifs (GLLG and YF) 
(1.8.4) are highlighted in yellow. The peroxidatic cysteines are shown in red text, while other 
cysteines, which may be resolving cysteines, are highlighted in blue. T. aquaticus* refers to the 
protein sequence reported by Logan and Mayhew (Logan and Mayhew 2000)while the second 
sequence labelled T. aquaticus is that which was found in a search of the Thermus aquaticus 
genome. Proteins compared and Genbank accession numbers are: Homo sapiens (H. sapiens), 
AAH08435.1; Ignisphaera aggregans (I. aggregans), YP_003860235.1; Pyrobaculum aerophilum (P. 
aerophilum), NP_559755.1; Pyrococcus furiosus (P. furiosus), NP_578762.1; Sulfolobus 
acidocaldarius (S. acidocaldarius), YP_254780.1; Thermotoga maritima (T. maritima), NP_228616.1; 
Thermus aquaticus (T. aquaticus), AAF82118.1 and ZP_03495958.1. 
 
 
When sequences were compared, the conserved peroxiredoxin motif (PXXXTXXC) (1.5.2) 
was aligned in all sequences. Sequence comparisons showed that the most similar enzyme 
to hPrx3 was that of Thermus aquaticus previously identified (Logan and Mayhew 2000), 
which while only 40% identical, conserved the amino acid sequence around both the 
peroxidatic and the resolving cysteine (C169 in H. sapiens), indicating that it is most likely a 
typical 2-cysteine peroxiredoxin of the AhpC-Prx1 class. 
Chapter Three: Results and Discussion (TaqPrx)   63 
 
3.1.2 BLAST comparisons of reported peroxiredoxins in T.aquaticus 
After PCR failed to amplify any products with primers for this gene (3.2), a BLAST alignment 
was used to compare the protein sequence to that reported in the Genbank database 
(www.ncbi.nlm.nih.gov/genbank/) in order to identify if any other similar proteins were known 
in related bacterial species. However, it was found that the amino acid sequence reported by 
Logan and Mayhew (2000) was almost identical to a protein found in the bacterium 
Geobacillus stearothermophilus (GenBank accession number YP_148428.1), showing only 
one amino acid difference. Many other peroxiredoxins of Geobacillus species are highly 
similar (80-90% identical) to the sequence proposed by Logan and Mayhew (2000). The 
genome of T. aquaticus published by Oak Ridge National Laboratory 
(http://genome.ornl.gov/microbial/taqu/) was then compared to the gene sequence of the 
enzyme identified by Logan and Mayhew (2000). The gene sequence was not identified in 
the T. aquaticus genome, nor were any sequences with significant similarity. Professor 
Mayhew was contacted, although he had subsequently retired. He suggested that the 
difference seen between the published T. aquaticus genome and the gene reported in his 
paper (Logan and Mayhew 2000) was due to differences in strain used. However, the high 
degree of similarity between the reported T. aquaticus gene and that of Geobacillus makes it 
seem likely that a Geobacillus species is the origin of the gene, whether due to 
contamination or horizontal gene transfer. 
The genome search also identified a 157 residue protein called 'alkyl hydroperoxide 
reductase/ Thiol specific antioxidant/ Mal allergen' showing a degree of similarity. This 
protein contained the PXXXTXXC (1.5.2) motif conserved in almost all known 
peroxiredoxins. The protein sequence was obtained and compared to the NCBI protein 
database by BLAST, and was found to be most highly similar to peroxiredoxins from 
Thermus scotoductus and Thermus thermophilus, and very similar to peroxiredoxins of 
closely related thermophilic bacterial genera such as Deinococcus, Marinithermus, and 
Meiothermus. As genomic DNA for T. aquaticus had already been obtained, this protein was 
chosen for analysis. 
Sequence analysis reveals that T. aquaticus Prx is 31% identical to hPrx3. Comparison of 
the sequence to the PREX database (http://csb.wfu.edu/prex/) (Soito et al. 2010) indicated it 
was a peroxiredoxin of the BCP-PrxQ group, a predominantly monomeric group. As the 
protein contains a second cysteine five residues after the peroxidatic cysteine, it could 
function as an atypical 2-Cys Prx, as other Prx in this family are known to have a resolving 
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cysteine in this position (Karplus and Hall 2007). This protein was termed TaqPrx, and the 
gene that encodes it TaqPRDX1. 
3.2 PCR and transformation 
Once identified, TaqPRDX1 was amplified from genomic DNA and cloned into a plasmid 
vector. E. coli were transformed by the plasmid in order to express the protein. The Gateway 
cloning system was used to clone TaqPRDX1 from genomic T. aquaticus DNA to the pDEST 
17 plasmid (4.3). This technique uses a two-step PCR process to introduce the desired gene 
into a plasmid (Hartley 2000). The first step uses gene specific primers to amplify the gene 
from genomic DNA, and adds small adaptor sequences on either end. The second step uses 
generic primers that attach to the adaptor sequences added by the first primer pair. This 
creates a linear fragment of DNA containing the gene of interest flanked by adaptor regions 
called attB1 and attB2. 
The next step is to transfer the fragment into a plasmid. To do this, an enzyme called BP 
clonase is used. This swaps the sequence from the fragment into a donor plasmid called 
pDONR221. This contains a gene for a toxic protein flanked by adaptor regions termed attP1 
and attP2. This reaction, which results in the fragment being integrated into the donor 
plasmid, is called the BP reaction. Since donor plasmids that do not undergo the BP reaction 
contain the gene for the toxic protein, only plasmids where the reaction was successful can 
grow. Insertion of the fragment can be checked using a BsrG1 digest, which cleaves 
fragment from the plasmid (Walhout et al. 2000). 
From the donor plasmid, the gene can be transferred into an expression plasmid. This uses 
a similar process, termed the LR reaction, using the enzyme LR clonase. The donor plasmid 
contains a pair of adaptor sequences called attL1 and attL2, while expression plasmids 
contain a pair called attR1 and attR2. LR clonase swaps the fragment from the donor 
plasmid to the expression plasmid, which again contains the gene for the toxic protein 
between its attR1 and attR2 (Walhout et al. 2000). 
The advantage of this technique is that it does not require a pair of restriction enzymes to be 
found that do not have a recognition site with the gene of interest, and allows genes to be 
quickly swapped into different expression enzymes (Katzen 2007). 
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Figure 3.2: (A) Agarose gel showing results of the attempted amplification of the T.aquaticus 
peroxiredoxin previously reported (Logan and Mayhew 2000) from genomic T. aquaticus DNA. Lane 
1: Attempted amplification of the gene, annealing temperature 65°C. Lane 2: The same reaction, 
annealing temperature 58°C. Lane 3: The same reaction, annealing temperature 51°C. Lane 4: The 
same reaction, annealing temperature 45°C. Lane 5: Control reaction. Lane 6: 1 kb plus DNA ladder. 
(B) Agarose gel showing results of PCR steps. Lane 1: Amplification of TaqPRDX1 gene from T. 
aquaticus genomic DNA, annealing temperature 65°C. Lane 2: The same reaction, annealing 
temperature 60°C. Lane 3: Addition of clonase recognition sites to amplified gene. Lane 4: 1 kb plus 
DNA ladder. (C) Agarose gel showing BsrG1 digest of pDONR 221 plasmid after insertion of 
TaqPRDX1 gene. Lanes 1-6: Plamid samples. Lane 7: 1 kb plus DNA ladder.  Protein band is 
highlighted with a blue box. (D) Agarose gel showing BsrG1 digest of pDEST 17 plasmid after 
insertion of TaqPrx gene. Lanes 1–2: Plasmid samples. Lane 3: 1 kb plus DNA ladder. 
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Attempts to amplify a peroxiredoxin gene from genomic T. aquaticus using primers 
corresponding to the sequence identified by Logan and Mayhew (2000) showed no evidence 
of amplification apart from nonspecific amplification at low annealing temperatures (Figure 
3.2A). None of the bands seen in the low annealing temperature reactions are consistent 
with the expected size of the gene, 564 bp. The control reaction shows that the lack of 
amplification was not due to errors in the method used to prepare reactions. 
When primers for the TaqPRDX1 were used, successful amplification was achieved (Figure 
3.2B). The upper bands in lanes 1 and 2 show the amplified gene, with a length of 
approximately 500 bp, consistent with the expected 498 bp. The lower bands in these lanes 
show species of much lower molecular weight, most likely primer dimers. Lane 3 shows the 
addition of attB1 and attB2 sites by the second set of Gateway primers. The upper band 
corresponds to a size of approximately 550 bp, consistent with the expected 562 bp for the 
gene with the attB1 and attB2 sites attached. This lane also shows evidence of primer 
dimers. Although the band for product was faint, enough DNA was present to allow the next 
step. 
After the gene had been transferred into the pDONR 221 plasmid (7.2.2), plasmid DNA was 
extracted from 6 colonies and checked for the presence of inserts by BrsG1 digest (7.2.4). 
Analysis of this reaction by gel electrophoresis (Figure 3.2C) revealed that an insert was 
present in lane 5, indicated by a band near 550 bp. Lanes 1-6 show a band near 2.8 kDa, 
indicating the presence of plasmid. A sample corresponding to lane 5 was used for the next 
reaction, transfer into the pDEST 17 plasmid (7.2.6). After cells had been transformed with 
the product of this reaction, plasmid was extracted and examined for the presence of insert 
by BsrG1 digest.  Analysis of this reaction by gel electrophoresis (Figure 3.2C) showed that 
both samples examined contained an insert of the appropriate size, approximately 550 bp. 
Both samples also showed a pair of bands corresponding to a larger species. These bands 
are due to plasmid, with the paired bands likely caused by incomplete digestion of the 
plasmid by BsrG1. Sequencing of the plasmid with M13 primers confirmed that the plasmid 
contained the TaqPRDX1 gene in the correct orientation and reading frame. 
3.3 Overexpression and purification of TaqPrx 
The method used for the overexpression and purification was based on that used in the 
purification of hPrx3 and is described in (7.3). After incubating cells overnight, E. coli Rosetta 
cells were harvested by centrifugation. Cells were lysed using a cell press, and debris was 
removed using centrifugation. 
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His-tagged TaqPrx was separated from the bacterial lysate using nickel affinity 
chromatography. After dialysis, His-tags were cleaved by incubation with 1 mg of TEV 
protease overnight. Cleaved TaqPrx was separated from any uncleaved protein, His-tags, 
and TEV protease using nickel affinity chromatography. After dialysis, a final purification step 
used anion exchange to produce TaqPrx. The concentration of purified TaqPrx was 
examined using a NanoDrop Spectrophotometer, measuring at 280 nm.Purification 
produced yields of TaqPrx of up to 20 mg per litre of culture. Protein purity was examined by 
SDS-PAGE (Figure 3.3). 
 
Figure 3.3: Purification of TaqPrx. Lane 1: Purified TaqPrx after anion exchange. Lane 2: TaqPrx 
after TEV cleavage. Lane 3: Nickel affinity column flowthrough. Lane 4: His-tagged TaqPrx. Lane 5: 
Bacterial lysate. Lane 6: Cell debris pellet. Lane 7: Novex Sharp pre-stained protein standard. 
3.4 Melting temperature analysis or TaqPrx 
The denaturation temperature of TaqPrx was investigated to test whether it displayed the 
high level of thermal stability expected in thermophilic bacterial protein. This was achieved 
by heating the protein in the presence of a dye that binds to hydrophobic regions of protein 
in a Bio-Rad iCycler iQ5 and measuring the absorbed fluorescence (7.4). When the protein 
denatures, hydrophobic regions are exposed, so a rapid increase in fluorescence is 
observed. 
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Figure 3.4: (A) Relative fluorescence measured with increasing temperature. (B) Change in relative 
fluorescence with increasing temperature. The large negative peak shows the point of most rapid 
increase in relative fluorescence, indicating exposing of hydrophobic protein regions due to 
denaturation. 
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In all samples, a high degree of initial fluorescence is present. A possible cause of this is that 
the protein is aggregating in the presence of the Sypro Orange dye. However, as 
temperature increases, this decreases, and a clear change in relative fluorescence can be 
seen (Figure 3.4A). Maximum increase in change occurs at 87.5°C (Figure 3.4B), revealing 
this as the denaturation point of TaqPrx. This shows that the enzyme is thermostable, 
consistent with its production by T. aquaticus, which grows optimally at approximately 75°C 
and can tolerate temperatures of up to 80°C (Brock and Freeze 1969).  
3.5 Quaternary structure of TaqPrx by DLS 
From its sequence, it was determined that TaqPrx is a member of the BCP-PrxQ group of 
enzymes (3.1), of which monomeric and dimeric forms are known. To determine the size of 
the species present, dynamic light scattering was used. This technique passes laser light 
through the sample, and detects the intensity of any scatter caused by particles in solution. 
As particles move through the laser, the change in intensity of scattering is recorded. This 
can be used to determine the hydrodynamic radius of the particles, as larger particles move 
more slowly than smaller ones. Larger particles scatter much more intensely than smaller 
ones, so samples must be free of large contaminants. Samples with particles of multiple 
sizes present are said to be polydisperse. The viscosity of the solution the particles are in 
must also be known, as this affects the rate of particle motion (Berne and Pecora 2000). 
Samples are analysed using a statistical technique called the cumulant method. This gives a 
measure of the size of particles present, as well as the level of polydispersity, called the 
polydispersity index (PdI). A PdI of ~0.2 or lower indicates that a sample contains particles of 
uniform size, while a PdI of over ~0.5 indicates a sample is highly polydisperse (Koppel 
1972; Frisken 2001). 
Size distribution was analysed in three different ways: By intensity, which determines what 
proportion of the observed scattering was produced by each species present; by number, 
which evaluates the number of each species giving rise to scattering present; and by 
volume, which evaluates the total volume of each species giving rise to scatter. All are 
derived from the cumulant analysis of intensity. 
Samples of 1 mg/ml TaqPrx were measured in phosphate buffered saline solution (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4. 1 mM KH2PO4, pH 7.4),examined using a Malvern 
Zetasizer Nano and analysed using the Zetasizer software. Three measurements were 
combined to estimate the size of the protein. The combined sample showed a high level of 
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polydispersity, with a PdI of 0.432 and a SD of 0.265. This indicates that multiple species are 
present in solution.  
However, by number and volume, over 99% of material present was located in one peak. 
This indicates that the polydispersity observed is caused by a very small number of very 
large particles, most likely a small amount of TaqPrx aggregates. 
By volume, this peak corresponded to an average radius of 1.740 nm with a SD of 0.057 nm 
and a peak width of 0.40 nm. By number, the peak corresponded to an average radius of 
1.990 nm with a SD of 0.038 nm and a peak width of 0.527 nm. The low  
These radius measurements indicate that the species present has a radius of approximately 
17.4 to 19.9 Å. When the monomer crystal structure of another protein of the BCP-PrxQ 
class, from Sulfolobus sulfataricus (PDB number 3DRN (D’Ambrosio et al. 2009)) was 
examined, it was found to have a radius of approximately 20 Å. This shows that the DLS 
data is consistent with TaqPrx being a monomeric peroxiredoxin. 
3.6 Structural homology modelling 
In order to further investigate the structure of TaqPrx, a homology model was made using 
the online modelling software SWISS-MODEL (http://swissmodel.expasy.org/) (Kiefer et al. 
2009). This program uses a BLAST search to identify a protein sequence with a crystal 
structure in the PDB and aligns them to the query sequence to find the best match. This is 
used as the basis of the model. The EVA-CM project (Koh et al. 2003) has been used to 
evaluate the accuracy of the SWISS-MODEL program, and shows that it compares 
favourably to other prediction programs. However, when the sequence identity of the query 
protein and the model is based on is over ~30%, all programs showed a similar level of 
accuracy. 
3.6.1 Homology model of TaqPrx 
The homology model produced by SWISS-MODEL used a peroxiredoxin from the archaen 
S. sulfataricus as the basis for its model (PDB number 3DRN). This protein has been shown 
to function with an atypical 2-Cys mechanism (D’Ambrosio et al. 2009). The two proteins 
belong to the same group, the PrxQ-BCP, and show 43% sequence identity, indicating that it 
likely has a very similar structure to TaqPrx.  
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Figure 3.5: (A) Homology model of TaqPrx produced by SWISS-MODEL. (B) Alignment of TaqPrx 
(green) and S. Sulfataricus bcp 1(3DRN (D’Ambrosio et al. 2009)). (C) Alignment of TaqPrx (green) 
and hPrx3 (yellow) (1ZYE). (D) Alignment of key active site residues. Colours are as previously 
assigned. In S.sulfataricus bcp 1, the active cysteine has been mutated to a serine. 
The core peroxiredoxin fold of 5 antiparallel β-sheets with flanking α-helices is conserved by 
the homology model (Figure 3.5A). It aligns very closely to S. sulfataricus bcp 1 with an 
RMSD of 0.08 Å over 129 atoms (Figure 3.5B), although this is expected as the model was 
based on this protein. However, it also aligns well to the much more distantly related bovine 
Prx3 (PDB number 1ZYE), which has a sequence identity of 31% with TaqPrx. The RMSD is 
1.5 Å over 115 atoms (Figure 3.5C), with the main differences being in the positions of the 
loops between the secondary structural elements. Active sites also align well, with the key 
catalytic residues being positioned very similarly. The main difference is in the orientation of 
the arginine residue; however, both conformations have been previously identified in a 
survey of peroxiredoxin crystal structures (Hall et al. 2010).  
3.6.2 Evaluation of homology model accuracy 
In order to draw useful conclusions from the homology model, its accuracy was evaluated. 
The SWISS-MODEL program uses QMEAN4 to examine the model quality. This technique 
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combines 4 statistical terms – the torsion angles between sets of three amino acids, two 
measures of distant dependent interaction potentials (one between Cβ only and the other 
between all atoms in the structure) and a solvation potential (Benkert, Tosatto, and 
Schomburg 2008). These terms are weighted and combined to give a value between 0 and 1 
for the homology model. This number is compared to QMEAN4 values of a library of high 
resolution crystal structures. QMEAN4 scores are then compared to a library of QMEAN4 
derived from high resolution X-ray structures from the PDB, and their difference from the 
mean is calculated. This value is called the Z-score QMEAN (Benkert, Biasini, and Schwede 
2011). Z-scores are also given for each of the terms used to make up the Z-score QMEAN. 
QMEAN scores can also be calculated per residue, termed QMEANlocal (Benkert, Schwede, 
and Tosatto 2009). This is calculated for a set of 9 amino acids at time, moving forward one 
amino acid per frame. This calculation uses the same terms as the QMEAN4 as well as 
terms for solvent accessibility and the proportion of residues not in a secondary structure. 
This can be used to estimate the accuracy of different sections within a model.  
 
Figure 3.6: (A) Comparison of QMEAN4 score of the TaqPrx homology model to a library of scores 
from crystal structures in the PDB. The black area defines proteins that are within 1 standard score of 
the mean, while lighter shades indicate scores further from the mean. The red mark shows the 
position of the TaqPrx homology model. (B) Homology model showing estimated levels of reliability 
per residue using QMEANlocal. Blue regions have high QMEANlocal scores, indicating higher 
accuracy; while red have lower scores and lower accuracy. 
The homology model of TaqPrx gives a QMEAN4 score of 0.76, and a Z-score QMEAN of  
-0.41 (Figure 3.6A). This indicates that the model’s QMEAN4 score is within one SD of the 
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mean for proteins of similar length, indicating it is likely to be accurate. Examining the 
QMEANlocal scores (Figure 3.6B) shows that the central β-sheet and main α-helices 
including the active site show the most accuracy; while loops and peripheral α-helices have 
lower accuracy. This shows that TaqPrx is very likely to contain the conserved 
peroxiredoxins fold. The inaccuracy in the loop regions is not unexpected, as these regions 
are more variable across the peroxiredoxin family (Karplus and Hall 2007). 
The homology model has a diameter of approximately 20 Å, correlating well with DLS (3.5). 
3.7 Sparse matrix crystal screening 
X-ray crystallography allows the very accurate determination of a proteins structure, as the 
position of every atom can be obtained. However, it requires protein to be in the crystalline 
state. For a protein to crystallise, it must be of sufficient concentration and in conditions that 
allow crystals to form and grow. Conditions allowing crystal formation and growth vary widely 
among proteins and are not easily predictable, so screens of a large number of conditions 
are carried out to look for evidence of crystallisation. 
3.7.1 Initial screening 
Screens were carried out to search for conditions that allowed crystals of TaqPrx to form. 
TaqPrx was screened at 10 mg/ml, using a custom screen based on Hampton Crystal 
Screen, Hampton Crystal Screen 2 and Hampton Index screen. These screens cover a 
broad range of conditions and have been widely used for protein crystallisation. 
Two conditions in the first screen showed the formation of crystalline structures (Figure 
3.7A). Both conditions produced small clusters of thin, needle shaped crystals. A fine screen 
of similar conditions resulted in slightly different crystal morphologies, but no usable crystals 
(7.7.1). Seeding growth by streaking crystal clusters into conditions from the fine screen 
where crystals did not form allowed the formation of another cluster like crystalline form, but 
did not yield any usable crystals (Figure 3.7B). 
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Figure 3.7: Representative photographs of cluster shaped crystal forms. (A) Cluster shaped crystals 
formed in 2 M (NH4)2SO4, 0.1 M CH3COONa, pH 4.6. (B) Cluster shaped crystals formed seeding 
crystal growth in 1.3 M (NH4)2SO4, 0.1 M CH3COONa, pH 4.5 by streaking crystals from 1.6 M 
(NH4)2SO4, 0.1 M CH3COONa, pH 4.5. 
3.7.2 JCSG+ and PACT screens 
As the previous screen (3.7.1) did not produce usable crystals, a second sparse matrix 
screen was carried out using two screens, the JCSG+ and PACT screens from Qiagen. 
These screens have proven successful in the past for protein crystallisation, and covers 
conditions not used in the previous screen. 
In this screen, small triangular crystals were seen in conditions of 200 mM LiSO4, 50% v/v 
PEG 400, 0.1 M CH3COONa, pH 4.5 (Figure 3.8). However, these showed poor diffraction 
when examined at the MX1 Beamline at the Australian Synchrotron. A fine screen at similar 
conditions attempted to produce more useful crystals, but no crystals were observed under 
the conditions used (7.7.2). 
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Figure 3.8: TaqPrx crystals formed in the JCSG+ screen in 200 mM LiSO4, 50% v/v PEG 400, 0.1 M 
CH3COONa, pH 4.5. The largest crystal is approximately 0.05 mm across. 
3.8 Activity assay of TaqPrx 
In order to confirm that TaqPrx is a peroxiredoxin, an assay to measure its peroxide activity 
was necessary. The assay used for hPrx3 (2.5) requires the activity of the peroxiredoxin to 
be close to that of horseradish peroxidase, and was therefore unsuitable. Instead, an assay 
based on mass spectrometry was developed with Dr Alexander Peskin from the University of 
Otago Centre for Free Radical Research. Samples of TaqPrx were examined in three 
conditions: Untreated, treated with H2O2 then N-ethyl maleimide (NEM) (termed the oxidised 
sample), and treated with NEM alone (called the blocked sample).  
NEM reacts with cysteine thiol groups to form thioesters, while a thiol group that has reacted 
with peroxide would not. TaqPrx contains two cysteine residues (3.1) and thus two thiol 
groups. However only the peroxidatic cysteine would be expected to react with peroxide as 
the active site of peroxiredoxins favours the thiolate state.  
Untreated conditions acted as a negative control, as there should be no oxidised derivatives 
in this sample. The oxidised sample shows if peroxide reduction is taking place. If TaqPrx 
has peroxide reducing activity, the peroxidatic cysteine would react with H2O2, creating an 
oxidised cysteine derivative. When NEM is added, it would react with the second cysteine, 
forming a species containing both an oxidised cysteine and an NEM blocked cysteine. 
However, if no peroxide reducing activity is present, a species containing two NEM blocked 
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cysteine residues would be observed. The blocked sample should contain this species as 
well, as both cysteines would react with NEM. All samples were examined by mass 
spectrometry by Dr Marie Squire from the University of Canterbury Department of Chemistry, 
using a Bruker maxis 3G mass spectrometer. 
CP CR MW (Da) CP CR MW 
 17813   17863 
  17815   17879 
  
17814   17940 
  17831   17956 
  17847   17972 
  17847   18065 
 
Table 3.1: Masses of possible species formed by adding H2O2 and/or NEM to TaqPrx. CP is the 
putative peroxidatic cysteine, CR is the putative resolving cysteine, NEM is N-ethyl maleimide, R is the 
rest of TaqPrx. 
The possible species that could be formed and their masses are shown in Table 3.1. It is 
unlikely that any species containing a sulfenic acid (R-SOH in Table 3.1) would be seen, as 
this species would be expected to react quickly with either the other cysteine in the protein, 
or a second H2O2 to form a sulfinic acid (R-SO2H) due to the large excess of H2O2  used. 
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Figure 3.9: Deconvoluted mass spectrum of untreated TaqPrx. Peaks are at 17812 Da and 17848 
Da. 
 
Figure 3.10: Deconvoluted mass spectrum of oxidised TaqPrx. Peaks are at 17812 Da and 17967 
Da. 
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Figure 3.11: Deconvoluted mass spectrum of blocked TaqPrx. Peaks are at 17812 Da and 17967 Da. 
In the untreated sample (Figure 3.9A) two peaks are seen. The first is at 17812 Da and 
shows a very strong signal. This corresponds most closely to the protein in the disulfide 
form. The second peak is at 17848 Da, and is much lower that the first peak. The most likely 
identity of this peak is the protein in the sulfinic acid form, which has a calculated mass of 
17847 Da. The presence of the second peak was unexpected, as no H2O2 was added to the 
protein.  
In the oxidised sample (Figure 3.9B), two peaks are again visible, the first corresponding to 
17812 Da, the same mass as the main peak in Figure 3.9A, and thus, the same species. 
The second peak has a mass of 18967 Da. This corresponds most closely in mass to a 
species with cysteine as a sulfinic acid and the other NEM blocked. However, this species 
has a calculated mass of 18972 Da, 5 Da more than the species observed.  
The blocked sample shows two peaks, one at 17812 Da and the other at 17817 Da (Figure 
3.9C). Neither peak corresponds to a NEM containing species. The smaller species is of the 
same mass as the species seen in the other two conditions, while the larger corresponds 
most closely to the protein in the dithiol form. 
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In the oxidised sample (Figure 3.9B) the mass of the larger species present is close to what 
was expected to be seen if TaqPrx displayed peroxiredoxin activity. The sulfinic acid 
(RSO2H) would be located on CP, due to it quickly reacting with H2O2 to form a sulfenic acid 
(R-SOH), the reacting with another H2O2 due to the excess concentration present. The 
smaller peak shows a species that has not reacted with either of H2O2 or NEM. Also, there is 
a lack of protein that has reacted with only NEM. An explanation for this could be that 
TaqPrx was present in a mixture of an oxidised, disulfide form and a reduced form. Protein in 
the reduced form would quickly react with hydrogen peroxide though CP, leaving a thiol 
group free to react with NEM. The disulfide population would be unable to react with either 
H2O2 or NEM, explaining the peak seen a 17812 Da. A summary of this proposed 
mechanism is shown in Figure 3.10. 
 
Figure 3.12: Proposed mechanism for the results seen in mass spectrometry of TaqPrx in the 
oxidised sample. (A) Initial solution contains both disulfide and dithiol TaqPrx. (B) The dithiol form of 
CP rapidly reacts with two H2O2 molecules to form a sulfinic acid derivative. (C) NEM reacts with the 
dithiol of CR. 
The other two samples, however, have less easily explainable peaks present. In the 
untreated sample (Figure 3.9A), a peak with a mass indicating the presence of a sulfinic acid 
was seen although no H2O2 was used in the preparation of this sample. A possibility is that 
this species formed during the purification of the protein, and all TaqPrx used contains a 
proportion in the sulfinic acid form. However in the sample treated with NEM alone (Figure 
3.9C), no such peak is present. This indicates that any sulfinic acid groups formed were not 
present before beginning the assay, as all protein used was from the same source. The 
sample also shows no evidence of NEM reacting with TaqPrx. 
While the assay does provide evidence for TaqPrx being a peroxiredoxin enzyme, further 
study is necessary to confirm this. A positive control using a known peroxiredoxin enzyme 
should confirm that one cysteine reacts with H2O2, while the other reacts with NEM, and a 
higher number of replicates would find if the unexpected results seen were consistently 
observed. 
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3.9 Summary of results 
Comparison of the sequences of thermophilic peroxiredoxins showed that the enzyme 
reported by Logan and Mayhew (2000) is unlikely to be present in T. aquaticus, but is likely 
to be from a bacterium of the Geobacillus genus. A gene was found in the T. aquaticus 
genome that showed evidence of being a peroxiredoxin of the BCP-PrxQ class, and was 
subsequently cloned, expressed and purified. 
Denaturation temperature analysis showed that TaqPrx exhibited the thermal stability 
expected in a protein from a thermophilic organism. DLS showed no evidence of any species 
larger than a monomer, while homology modelling gave strong evidence that the protein 
contained the core peroxiredoxin fold and conserved active site. Production of crystalline 
protein for X-ray crystallography was attempted, but while promising conditions were 
identified, useable crystals were not produced.  
The activity assay described gave some evidence that TaqPrx shows peroxiredoxin reducing 
activity. However, further experimentation is necessary to confirm these intial results. 
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CHAPTER FOUR 
Summary and Conclusions 
 
Many proteins demonstrate self-assembly, the formation of large structures from smaller 
basic units. This makes them attractive for use as nanoscale devices, as proteins are 
structurally and chemically diverse. Self-assembly in proteins is regulated by the structure of 
the monomeric units, using a variety of intermolecular forces. Peroxiredoxins are a diverse 
family of proteins with access to numerous oligomeric states, and exhibit redox controlled 
switching between larger and smaller forms. This makes them useful as a model system for 
investigating protein self-assembly. 
This study mainly focussed on human peroxiredoxin 3, which is known to form large, ring 
shaped structures from a small subunit. This enzyme was examined under a variety of 
conditions to identify which conditions affected the quaternary structure of the protein. Two 
modified variants of the enzyme were created and purified: hPrx3 S78A and His-tagged 
hPrx3. These were then compared to the wild type enzyme. 
In the purified wild type hPrx3, addition of reductant strongly favoured the formation of higher 
order structures, as reported in earlier literature for related peroxiredoxins. Increasing protein 
concentration also favoured oligomer formation, though not to as great an extent as the 
presence of reductant. Sodium phosphate buffer strongly favoured the formation of higher 
order structures compared to Tris buffer. Both increasing and decreasing pH favoured the 
dimer form when compared to pH 7.5; however, aggregation was apparent in many of these 
conditions. Analysis of SAXS measurements identified the two main species present as a 
having maximum diameters of 188 Å and 79 Å, and approximate masses of 293 kDa and 52 
kDa. Comparison of the scattering curves observed for each species with those calculated 
from the crystal structure of bovine Prx3 indicated that these corresponded to a dodecamer 
and a dimer, respectively. Electron microscopy showed ring shaped structures with an 
average diameter of 140 Å, again consistent with the higher order species seen being a 
dodecamer. 
The  hPrx3 S78A mutant was examined in order to investigate whether it displayed 
increased proportions of larger species than the wild type, as a similar mutation had been 
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previously been shown to favour self-assembly in a bacterial peroxiredoxin (Parsonage et al. 
2005). 
When the hPrx3 S78A protein was examined, the same general trends were seen in the 
factors that affected oligomerisation as in the wild type. However, a greater proportion of 
higher order species were seen compared to wild type hPrx3. This was seen in all conditions 
observed. The likely cause of this is that the serine residue formed a hydrogen bond to the 
solution in the wild type, and removing this removed an interaction favouring the dimeric 
form. There would also be a gain in stability for the dodecameric form due to the methyl 
group of the alanine being buried in the interface. 
In the His-tagged hPrx3 protein, the same trends seen in the wild type enzyme were 
observed. However, higher order species were very strongly favoured, with several 
conditions showing no observable presence of dimeric species. SAXS measurements 
showed that His-tagged hPrx3 has overall dimensions quite similar to that of the wild type, 
but has a significantly higher mass and volume. Its scattering curve did not match the 
dodecameric form, though it showed slightly more similarity to the calculated scattering of 
the catenane form of the protein. This may be caused by a change in the shape of the 
protein due to the His-tags. Examination of TEM images, however, revealed that 
dodecameric structures were present, with similar dimensions to those observed in wild type 
hPrx3.  
It was found that the addition of nickel ions to the His-tagged protein caused the protein to 
rapidly become insoluble. TEM analysis revealed that this was formed from dodecameric 
structures, with external diameters of 140 Å and internal diameters of approximately 46 Å. 
This is somewhat different than what is observed for His-tagged hPrx3 in the absence, 
indicating that the presence of metal ions may cause the His-tag regions to become more 
structured. A small population of stacks of rings was also observed. These represent another 
possible oligomeric structure peroxiredoxins can form, and in some conditions may be 
present in both wild type and His-tagged hPrx3, as evidence for species larger than the 
dodecamer was present in some chromatography experiments.  
Upon the addition of a chelating agent, a decrease in proportion of higher order species 
present was observed. This showed that metal binding played a role in favouring higher 
order species in His-tagged hPrx3. However, there was still a higher proportion of higher 
order species present than seen in the wild type enzyme, indicating that either metal binding 
does not completely explain the higher proportion of higher order species seen in His tagged 
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hPrx3, or that metal is bound too tightly for the chelating agent to fully remove. TEM images 
also revealed the presence of small stacks of rings. These represent another possible 
oligomeric structure peroxiredoxins can form, and in some conditions may be present in both 
wild type and His-tagged hPrx3, as evidence for species larger than the dodecamer was 
present in some chromatography experiments.  
Purification of His-tagged hPrx3 S78A was attempted; however, this protein proved unstable 
and quickly aggregated during purification. Electron microscopy showed that aggregates 
formed were not higher order species. Different purification conditions may be able to allow 
purification of this enzyme variant, which was predicted to show very strong preference for 
self-assembly. 
The activity of all three hPrx3 variants was analysed using a competitive assay with 
horseradish peroxidase. The wild type enzyme showed a kcat/km of 1.95 ×10
7, which is 
consistent with previously reported values for other peroxiredoxin enzymes (Ogusucu et al. 
2007; Nelson et al. 2011). In hPrx3 S78A, higher activity was seen, with a kcat/km of 4.30 
×107. hPrx3 S78A also favoured the dodecameric form compared to the wild type enzyme; it 
is possible that this higher activity is linked to this altered quaternary structure. A link 
between redox state and activity has been suggested in another peroxiredoxin enzyme 
(Parsonage et al. 2005). For His-tagged hPrx3, a kcat/km of 5.70 ×10
7 was seen. This is 
higher than what was observed for both the wild type hPrx3 and hPrx3 S78A, and as His-
tagged hPrx3 shows a very strong preference the dodecameric form, it is possible that the 
increased activity is due to its preference for the dodecameric form. However, the data could 
not be linearly fitted as well as that of the other two variants.  
A second enzyme was also examined, a thermophilic peroxiredoxin from the bacterium 
Thermus aquaticus. This was done to investigate if the protein also displayed self-assembly 
properties, and if these were significantly different from the mesophilic hPrx3. A combination 
of the redox controlled self-assembly and thermal stability would be useful for any 
nanodevices based on a peroxiredoxin enzyme. 
Examination of the genome of T. aquaticus and reported gene sequences in the Genbank 
database showed that the peroxiredoxin enzyme previously reported (Logan and Mayhew 
2000) is not present in T. aquaticus and is more likely from a bacteria of the genus 
Geobacillus. Instead, a potential peroxiredoxin gene was identified in the genome of T. 
aquaticus and cloned into a plasmid vector, allowing expression in E. coli and purification of 
the protein. Analysis of the sequence showed it belonged to the BCP-PrxQ group of 
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peroxiredoxins, and the presence of a second cysteine indicated it could use the atypical 2-
Cys reaction mechanism. 
After purification, the protein was investigated to determine its physical and biochemical 
properties. Dynamic light scattering measurement showed the protein was present as a 
single species, with an approximate diameter of 39 Å. This is close to the size of a monomer 
of related peroxiredoxin enzymes. Structural homology modelling of the protein using 
SWISS-MODEL agreed with this measurement, and suggested a protein structure 
containing the protein fold and active site conserved across all peroxiredoxins. Analysis of 
the melting curve of TaqPrx proved the thermal stability of the protein, giving a melting 
temperature of 87.5 °C, consistent with the known thermal tolerances of the T. aquaticus 
bacterium (Brock and Freeze 1969). 
A novel mass spectrometry based activity assay was developed to test for peroxide reducing 
activity in TaqPrx, utilising the high reactivity of the active cysteine for hydrogen peroxide. 
This suggested that TaqPrx demonstrated peroxide reducing activity, as high reactivity to 
hydrogen peroxide was observed in one of its two cysteine residues. However further 
experimentation is necessary to confirm this result. 
Crystals of TaqPrx were formed using the JCSG+ crystal screen. X-ray diffraction diffraction 
was poor, and fine screening was unable to produce for useful crystals. Further research 
would aim to produce a crystal structure for this enzyme, as it would confirm its structure as 
a member of the BCP-PrxQ peroxiredoxin group.  
The experiments carried out on the peroxiredoxin of T. aquaticus confirmed that it has 
peroxiredoxin activity and a high level of thermal stability. They also showed that it lacks the 
self-assembly properties seen in the human peroxiredoxin investigated. However, it is likely 
that thermophilic enzymes exist that do display self-assembly, and identifying and 
investigating such enzymes would allow insight into how oligomerisation can be controlled at 
higher temperatures. 
It was shown variant forms of peroxiredoxin enzymes can be produced by protein 
engineering that display altered quaternary structures, and that variants with altered 
quaternary structures show evidence of altered enzymatic activity. Further research could 
look at other mutations to residues involved in self-assembly either in the A-type interface, or 
in the regions closer to the active site involved in the structural shifts seen during catalysis. 
Another area to investigate is the interfaces involved in forming the stacks of rings seen in 
His-tagged hPrx3. A second result was the purification and identification of activity of a 
Chapter Four: Summary and Conclusions   85 
 
previously unknown monomeric peroxiredoxin from T. aquaticus. While this protein does not 
show oligomeric activity, it does represent a member of a less well studied group of 
peroxiredoxins. Future work could aim to solve a crystal structure for this enzyme to confirm 
its structure.  
In order to produce protein based self-assembling nanoscale devices, knowledge of the 
properties of proteins that allow this behaviour self-assembly is required. The work described 
in this thesis shows that peroxiredoxins are a useful model system for the investigation of 
these properties by protein engineering. 
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CHAPTER FIVE 
General Methods 
5.1 Chemicals, buffers and equipment 
Chemical were generally purchased from Sigma-Aldritch, Invitrogen and Ajax Finechem. 
Protein standards for SDS-PAGE and SEC were purchased from Bio-Rad. Gateway cloning 
enzymes and DNA gel standards were purchased from Invitrogen. DNA and protein dyes 
were purchased from Roche. Filters were purchased from Sartorius Stedium Biotech. All 
columns used were from GE Healthcare. 
All buffers were made in deionised water, except for buffers for TaqPrx activity assays (7.8)  
which used ultrapure water from Sigma. All buffers filtered using vacuum filtration. Buffer pH 
was adjusted by addition of HCl and NaOH and measured using a Denver Instrument UB-10 
pH meter. 
OD600 of cells was measured using a Bio-Rad Smartspec Plus spectrophotometer. 
SDS-PAGE was carried out using a Bio-Rad Mini-PROTEAN Tetra Cell electrophoresis 
using precast gels. 
All chromatography was carried out using a GE ÄKTA Explorer FPLC system. Samples were 
monitored by measuring UV absorbance at 280 nm. 
For volumes of over 50 ml, centrifugation was carried out using a Sorvall RC6 plus 
centrifuge. For smaller volumes, either an Eppendorf 5819R centrifuge or an Eppendorf 
Minispin Plus centrifuge was used. 
Protein was concentrated using Vivaspin 6 and 20 columns from GE Healthcare, using the 
appropriate molecular weight cutoff value for the protein used. 
Protein concentration was measured using a NanoDrop ND 1000 spectrophotometer from 
Thermo Scientific after blanking with appropriate buffer, measuring absorbance at 280 nm. 
All calculated molecular masses were found using the online tool Compute pI/MW tool from 
ExPASy (http://web.expasy.org/compute_pi/). 
Chapter Five: General Methods  87 
 
5.2 Bacterial cultures 
All E. coli cultures were grown in sterile 20 gL-1 lysogeny broth (LB) in deionised water with 
the appropriate antiobiotics, shaking at 160 rpm. LB media were sterilised by autoclaving at 
121°C. LB/Agar plates used for the growth of E.coli colonies were made using 20 gL-1 LB 
and 15 gL-1 agar dissolved in deionised water. This was sterilised by autoclaving at 121°C. 
Media were poured into sterile Petri dishes in a laminar flow hood and allowed to set before 
being sealed and stored at 4°C. Single colonies used to inoculate cultures were transferred 
using a sterile micropipette tip. Appropriate antibiotics were used in all cultures. Ampicillin 
(Amp) was used at 100 µg/ml, kanamycin (Kan) and chloramphenicol (Chl) were used at 30 
µg/ml, and tetracycline was used at 15 µg/ml. 
5.3 Plasmid extraction 
Plasmids were purified from bacteria with an alkaline lysis based method using an Axygen 
Axyprep Plasmid Miniprep Kit. Bacteria were cultured overnight in 10 ml LB medium at 37°C. 
4 ml of bacterial culture was pelleted by centrifugation at ~12,000 ×g for 1 minute. The 
supernatant was discarded and the pellet was resuspended in 250 µl of resuspension buffer. 
250 µl of lysis buffer was then added, and the solution was mixed by inversion. 350 µl of 
neutralisation buffer was added and mixed by inversion. The solution was then centrifuged 
for 10 minutes at ~12,000 ×g, and the supernatant was transferred to a Miniprep column. 
This was centrifuged at ~12,000 ×g for 1 minute. 700 µl of wash buffer was applied to the 
column, which was again centrifuged for 1 minute at ~12,000 ×g. The filtrate was discarded, 
and 40 µl of eluant preheated to ~50 °C was added. This was allowed to stand for 1 minute 
at room temperature, before centrifugation for 1 minute at 12,000 ×g. Plasmid concentration 
was examined using a NanoDrop spectrophotometer measuring at 280 nm. 
5.4 DNA gel electrophoresis 
DNA gel electrophoresis was used to measure the size of plasmids and DNA fragments of 
interest. DNA gel electrophoresis was carried out using a 1% agarose/TAE gel, which were 
made by adding 0.3 g of agarose to 30 ml of TAE buffer (40 mM Tris, 20 mM acetic acid, 1 
mM EDTA, pH 8.0). 3 µl of SybrSafe DNA dye was added to visualise DNA. Samples were 
prepared by adding 10 µl of sample to 2 µl of loading dye. 5 µl of 1 kb plus DNA ladder was 
used to estimate the size of sample DNA. Electrophoresis was carried out in TAE buffer, 
running at 110 V for 60 minutes. Gels were examined under UV light using a Syngene 
Chemi Genius2 Bioimaging System. 
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5.5 Production of chemically competent cells 
Cells were streaked out on LB/agar plates (containing Tet for XL1 Blue cells) and incubated 
overnight at 37 °C. Single colonies were used to inoculate 5 ml LB cultures, which were 
incubated overnight at 37 °C with shaking at 160 rpm. 4 ml was used to inoculate a 200 ml 
culture, which was incubated at 37 °C until it reached an OD600 of ~0.8. The culture was then 
cooled on ice for 15 minutes in sterile centrifuge bottles before centrifugation at 4,000 ×g for 
10 minutes at 4 °C. Cells were resuspended in 40 ml of cooled, sterilised 100 mM CaCl2, 
and then harvested by centrifugation at 4,000 ×g for 10 minutes at 4°C. Cells were finally 
resuspended in 8 ml 100 mM CaCl2, and then frozen in liquid nitrogen in 100 µl aliquots. 
Competent cells were stored at -80°C. 
5.6 Heat shock transformation 
Transformation of chemically competent XL1 Blue and DH5α Escherichia coli (E. coli) cells 
was achieved using a heat shock method. Chemically competent cells were defrosted on ice 
in 100 µl aliquots. 1 µl of plasmid was added, and samples were incubated on ice for 30 
minutes. Samples were heat shocked for 30 seconds at 42 °C. 1mL of LB media preheated 
to 37 °C was added, and samples were incubated at 37 °C with shaking at 160 rpm for 60 
minutes. Cultured cells were pelleted by centrifugation at ~5,000 ×g for 1 minute. 900 µl of 
supernatant was removed and the pellet was resuspended in the remaining solution. This 
was used to inoculate an LB/Agar + Amp plate, which was incubated overnight at 37 °C. 
Single colonies were selected and used to inoculate 10 ml LB media, which was incubated 
overnight at 37 °C with shaking at 160 rpm. Plasmid was extracted from cells (5.3). This was 
then used to transform chemically competent BL21 Star™ (DE3) cells using the above 
method. 
5.7 Preparation of freezer stocks 
Bacterial cells were cultured overnight at 37 °C in 10 ml of LB containing antibiotics 
appropriate for their growth. 1.5 ml of culture was harvested by centrifugation at ~12,000 ×g 
for 1 minute. This was resuspended in 750 µl of LB medium. 750 µl of 30% glycerol was 
added to the culture, and samples were frozen using liquid nitrogen and stored at -80 °C. 
5.8 Protein SDS-PAGE 
Protein gel electrophoresis was carried out using Bio-Rad Mini-PROTEAN TGX precast gels. 
Samples were prepared by adding 5 µl of protein sample to 4.75 µl Laemmli buffer and 0.25 
µl β-mercaptoethanol, then heated at ~90°C for 5 minutes. 5 µl of Bio-Rad Precision Plus 
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Protein WesternC protein standard was used to determine band size. Gels were run for 30 
minutes at 200 V. Gels were washed in deionised water for 2 minutes, then stained using 
SimplyBlue Coomassie-G250 stain. 
5.9 Expression and purification of Tobacco etch virus protease  
Tobacco etch virus (TEV) protease was expressed in E. coli and purified using a method 
based on that of Blommel and Fox (2007), which produces protease with a non-cleavable 
His-tag and a fused, TEV protease cleavable maltose binding protein domain (MBP). This 
increases solubility and yield. Single colonies of BL21 (DE3) E. coli containing a plasmid 
encoding the TEV gene were grown on a LB/Agar + Kan + Chl were used to inoculate 10 ml 
LB cultures. These were grown overnight at 37 °C overnight with shaking at 160 rmp, and 
were used to inoculate 0.5 l LB + Kan cultures. When the A600 reached ~0.8, expression was 
induced by adding IPTG to a concentration of 0.5 mM. Cultures were then incubated at 26 
°C overnight with shaking at 160 rpm. Cells were harvested by centrifugation at 17,000 ×g 
and the supernatant was discarded. The cell pellet was resuspended in Buffer A (20 mM 
NaH2PO4, 500 mM NaCl, 0.3 mM TCEP, 50 mM imidazole, pH 7.5). Cells were lysed using a 
Microfluidics M-110P cell disrupter at 11500 Bar and cell debris was separated by 
centrifugation at 20,000 ×g. The supernatant was loaded onto a 5 ml GE HisTrapTM FF crude 
column, washed with the Buffer A and eluted using a gradient of Buffer B (20 NaH2PO4, 500 
mM NaCl, 0.3 mM TCEP, 500 mM imidazole, pH 7.5). Fractions containing protein were then 
desalted using a GE HiPrep™ 26/10 desalting column into Buffer C (10 mM Tris, 0.3 mM 
TCEP, pH 7.5). Protein was incubated at 4 °C for 1 hour to allow cleaving of the MBP-tag, 
then loaded onto a GE HiTrap™ Q Sepharose FF anion exchange column. Protein was 
eluted with a gradient of Buffer D (10 mM Tris, 1000 mM NaCl, 0.3 mM Tris, pH 7.5). Protein 
containing fractions were pooled and diluted with Buffer C to bring the protein concentration 
to ~2 mg/ml. The protein was separated into 500 µl aliquots, 500 µl of glycerol was added to 
each and samples were frozen in liquid nitrogen and stored at -80 °C.
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CHAPTER SIX 
Experimental Methods (hPrx3) 
 
Human peroxiredoxin 3 was examined in four forms: wild type hPrx3, His-tagged hPrx3, 
hPrx3 S78A, and His-tagged hPrx3 S78A to compare the oligomeric and self-assembly 
properties of each. 
6.1 pEt 151 plasmids 
Previous work in the Gerrard lab created (Zu and Littlejohn 2010, unpublished) a pEt 151 
plasmid containing the gene for hPrx3 as well as mutant plasmid containing the gene for 
hPrx S78A. This plasmid attaches an N-terminal His6-tag to the expressed protein. The tag 
is connected by a linker containing a TEV protease cleavage site and has the sequence:  
HHHHHHGKPIPNPLLALDSTENLYFQ*EIDPFT 
TEV cleavage occurs at the point marked with a ‘*’ leaving 6 non-native amino acids 
attached to the protein. The calculated molecular masses of the hPrx3 variants are as 
follows: Wild type hPrx3 is 22.0 kDa, His-tagged hPrx3 is 25.2 kDa, hPrx3 S78A is 22.0 kDa,  
His-tagged hPrx3 S78A is 25.2 kDa. 
6.2 Overexpression and purification 
The method used for overexpression and purification was based on that of (Gourlay et al. 
2003). Single colonies from LB/Agar + Amp plates were used to inoculate 10 ml LB + Amp 
cultures. These were grown overnight at 37°C with shaking at 160 rpm. These were used to 
inoculate 1 l LB + Amp cultures, which were grown at 37°C with shaking at 160 rpm until A600 
reached ~0.6. Synthesis of protein was induced by adding IPTG to 0.3 mM and incubating 
cells overnight at 26°C with shaking at 160 rpm. 
Cells were harvested by centrifugation at 8000 rpm and resuspended in a low imidazole 
buffer (30 mM imidazole, 500 mM NaCl, 20 mM NaH2PO4, pH 7.5). Cells were lysed by 
passing twice through a Microfluidics M-110P cell disrupter at 11500 Bar, and cell debris 
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was pelleted by centrifugation at 18000 rpm. Supernatant was loaded onto a 5 ml GE 
HisTrapTM FF crude column, washed with low imidazole buffer and eluted using a high 
imidazole buffer (300 mM imidazole, 500 mM NaCl, 20 mM NaH2PO4, pH 7.5), collecting in 1 
ml fractions. Fractions were examined for protein content using a NanoDrop 
spectrophotometer measuring at 280 nm. Fractions containing protein were pooled. 
1 mg of TEV protease was added to remove His-tags. This was then dialysed overnight into 
a cleavage buffer (20 mM Tris, 150 mM NaCl, 10 mM β-mercaptoethanol, pH 7.5), then 
incubated for 1 hour at 37°C. 
TEV protease, cleaved His-tags and uncleaved proteins were separated from cleaved 
protein using a 5 ml GE HisTrap FF Crude column. Low imidazole buffer to elute before 
washing any bound proteins from the column using high imidazole buffer. 1 ml fractions were 
collected and the protein concentration was determined using a NanoDrop 
spectrophotometer. Protein containing fractions were pooled and desalted into a storage 
buffer (20 mM Tris, 150 mM NaCl, pH 7.5) using a GE 5 ml GE HiPrep 26/10 desalting 
column.  
Cleaved protein was then desalted into a low salt buffer (20 mM Tris, pH 8.0) and loaded 
onto a GE HiTrap Q Sepharose FF anion exchange column. Protein was eluted using a 
gradient of high salt buffer (20 mM Tris, 1 M NaCl, pH 8.0). Samples containing protein were 
collected, then desalted into a storage buffer (20 mM Tris, 150 mM NaCl, pH 7.5). 
To produce protein with the His-tag attached, tagged protein was desalted into low salt 
buffer and loaded onto the anion exchange column. His-tagged protein was eluted with a 
gradient of high salt buffer and protein containing fraction were pooled and desalted into a 
storage buffer. 
Purification was analysed using SDS-PAGE (5.8). 
6.3 Transition electron microscopy 
Samples were prepared for examination by TEM using a Morgagni 268D TEM, measuring at 
100 kV and capturing images using a SIS/Olympus Megapixel III digital camera. Samples 
were prepared on copper grids coated with formvar, size 200 mesh from ProSciTech. 10 µl 
of protein was added, then rinsed 3 times with distilled water. Samples were then negatively 
stained using 3% uranyl acetate.  
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Wild-type and tagged wild-type protein was examined at concentrations of 1 and 10 mg/ml in 
20 mM Tris, 150 mM NaCl, pH 7.5 buffer. Tagged protein was also examined at 
concentrations between 3 and 5 mg/ml and NiCl2 concentrations of between 1, 2, 5 and 10 
mg/ml. 
6.4 Analytical size exclusion chromatography 
6.4.1 Concentration, pH and buffer variations 
Protein oligomeric structure was estimated using analytical size exclusion chromatography 
(SEC). A GE Sephadex 200 10/300 GL column was used. The column was first calibrated 
with Bio-Rad Gel Filtration Standards (bovine thyroglobulin, 670 kDa; γ-globulin, 158 kDa; 
chicken ovalbumin, 44 kDa; horse myoglobin, 17 kDa and vitamin B12, 0.135 kDa). Wild type 
hPrx3, hPrx3 S78A and His-tagged hPrx3 were examined in the following conditions: 
20 mM Tris, 150 mM NaCl, pH 7.5 
20 mM Tris, 150 mM NaCl, 10 mM DTT pH 7.5 
20 mM NaPi, 150 mM NaCl, pH 7.5 
20 mM NaPi, 150 mM NaCl, 10 mM DTT pH 7.5 
20 mM Tris, 150 mM NaCl, pH 9.0 
20 mM Tris, 150 mM NaCl, 10 mM DTT pH 9.0 
20 mM NaPi, 150 mM NaCl, pH 6.0 
20 mM NaPi 150 mM NaCl, 10 mM DTT pH 6.0 
At each condition, protein was analysed at concentrations of 1, 5 and 10 mg/ml. Elution was 
monitored for protein by recording the UV absorbance at 280 nm. 
6.4.2 EDTA and His-tagged hPrx3 
The oligomeric structure of His-tagged hPrx3 was investigated by SEC using a GE 
Sephadex 200 10/300 GL column. The column was calibrated with Bio-Rad Gel Filtration 
Standards (bovine thyroglobulin, 670 kDa; γ-globulin, 158 kDa; chicken ovalbumin, 44 kDa; 
horse myoglobin, 17 kDa and vitamin B12, 0.135 kDa). The protein was examined in 20 mM 
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Tris, 150 mM NaCl, 10 mM EDTA, pH 7.5, at concentrations of 1, 5 and 10 mg/ml. Elution 
was monitored for the protein by recording the UV absorbance at 280 nm. 
6.5 SAXS measurement 
SAXS measurements of wild type and wild type tagged hPrx3 were made at the SAXS-
WAXS beamline of the Australian Synchrotron in Melbourne, Australia. Proteins were 
examined at ~4 mg/ml in storage buffer (20 mM Tris, 150 mM NaCl, pH 7.5). Samples were 
run through a 3 ml gel filtration column at a flow rate of 0.2 ml/min before passing through a 
1 mm quartz capillary. Measurements were collected every 2 seconds, at 25 °C. Scattering 
intensity was compared to elution time, and measurements that showed protein were 
averaged. Scattering was normalised by comparison to water scatter and the resulting 
forward scatter was used to estimate the molecular weights of the scattering species. A 1.6 
m camera was used, which provided a q range from 0.01 to 0.5 Å-1, where q is the 
magnitude of the scattering vector, and is related to the scattering angle (2θ) and the 
wavelength (λ) by the equation: q = (4π/λ). Data were collected on a Pilatus 1M detector 
(170 mm×170mm, effective pixel size 172×12 µm) 
Averaging of images, subtraction of blanks and radial integration was performed using the 
beamline control software ScatterBrain (Australian Synchrotron). Further analysis was 
carried out using the ATSAS software package (Konarev et al. 2006; Petoukhov et al. 2012) 
from EMBL Hamburg (http://www.embl-hamburg.de/biosaxs/software.html).  
6.6 Competitive activity assay 
The activity of wild type, tagged wild type and S78A hPrx3 was estimated using a 
competitive assay with horseradish peroxidase (HRP). HRP contains a heme group that 
absorbs at 403 nm, but loses this absorbance when it reacts with H2O2. The assay compares 
the decrease of absorbance seen when hPrx3 is in competition with HRP for a limited 
amount of H2O2 and is based on that of Oguscu et al. (2007). 
Protein samples were reduced with 70 mM β-mercaptoethanol and incubated on ice for 60 
minutes. Samples were then desalted into 100µ 50 mM NaH2PO4, 100 µM DTPA, pH 7.5 
using a Bio-Rad Bio-spin 6 desalting column. This buffer was prepared with ultrapure water 
to ensure no oxidising agents were present. Exact protein concentration after buffer 
exchange was determined using the Lowry assay (Lowry et al. 1951). HRP concentration 
used in each assay was determined by measurement of absorbance at 403 nm, and that of 
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H2O2 used was determined by measurement of absorbance at 240 nm. Absorbance 
measurements were carried out using an Agilent 8453 UV-visible spectroscopy system in a 
quartz cuvette with a 10 mm path length. 
Absorbance was first measured of HRP alone, which was done by adding 5 µl of HRP was 
to 95 µl of buffer. Next, the absorbance of HRP in the presence of H2O2 was measured, by 
adding 5 µl of HRP and 5 µl of H2O2 to 90 µl of buffer. Absorbance of HRP was then 
measured in the presence of H2O2 and increasing concentrations of enzyme samples. 
Measurements were made immediately after addition of H2O2, to limit reduction of oxidised 
hPrx3 by reduced HRP. 
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CHAPTER SEVEN 
Experimental Methods (TaqPrx) 
 
7.1.1 Comparisons of thermophilic peroxiredoxin genes to hPrx3 
The amino acid sequences of six thermophilic peroxiredoxin enzymes from both bacteria 
and archaea were identified in the Genbank database (www.ncbi.nlm.nih.gov) (Benson et al. 
2000). From achaea, the amino acid sequences for peroxiredoxins from Pyrococcus 
furiosus, Pyrobaculum aerophilum, Sulfolobus acidocaldarius and Ignisphaera aggregans 
were identified, while from bacteria, sequences from Thermotoga maritima and T. aquaticus 
were identified. These were aligned together with the hPrx3 using Clustal Omega 
www.ebi.ac.uk/Tools/msa/clustalo/) (Sievers et al. 2011) to search for sequences similar to 
hPrx3. 
7.1.2 The TaqPRDX1 gene 
Genomic DNA from the bacterium T. aquaticus was obtained from Professor Hugh Morgan 
of the University of Waikato. Examination of the Genbank database found a gene that was a 
likely peroxiredoxin candidate, containing the key active site motif found in all Prx proteins. 
This was annotated as ‘Alkyl hydroperoxidase reductase/Thiol specific antioxidant/Mal 
allergen [Thermus aquaticus Y51MC23]’ with accession number ZP_03495958.1. Four other 
T. aquaticus proteins were identically annotated (Table X), however none contained the key 
peroxiredoxin catalytic motif, PXXXTXXC (1.5.2) (Poole 2007). Examination of the sequence 
using the Peroxiredoxin Classification Index (PREX) (www.csb.wfu.edu/prex/) (Soito et al. 
2010) showed that the protein was likely a 1-Cys peroxiredoxin in the BCP-PrxQ class. The 
sequence was also examined for rare codons using an online rare codon calculator tool, 
(www.nihserver.mbi.ucla.edu/RACC). 
7.2 Gateway cloning of TaqPRDX1 
7.2.1 PCR 
The TaqPRDX1 gene was cloned into a plasmid using the Gateway system from Invitrogen 
(Walhout et al. 2000). Primers were designed using the NetPrimer tool at 
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(www.premierbiosoft.com/netprimer/ ) and ordered from IDT DNA.  The sequence for the 
gene-specific primers was: 
Forward: 5' – GGC AGC GGC GCG ATG CCC GGC ATG GAA – 3' 
Reverse: 5' – GAA AGC TGG GTG CTA CTC CCC CCT TGC CT – 3' 
The bold section complements the genomic DNA sequence, while non-bold sections 
introduce binding sites for the second set of primers. 
Reactions contained: 
T. aquaticus genomic DNA  0.25 µl 
dNTP mix    2 µl 
5× PrimeSTAR® Buffer  5 µl 
Gene specific primer (forward) 0.75 µl 
Gene specific primer (reverse) 0.75 µl 
PrimeSTAR® HS Polymerase  0.25 µl 
dH2O     16 µl 
PCR was carried out in a Eppendof Mastercycle Gradient Thermocycler. Parameters were: 
Step   Temperature   Time  
Initial Denaturation 98°C   10 min   
25 Cycles of: 
Denaturation  98°C   5 sec   
Annealing  60 / 65°C  5 sec   
Extension  72°C   60 sec  
1 Repeat of:  
Final Extension 72°C   120 sec   
Hold   4°C   -   
Reactions were run at both 60°C and 65°C. Products were analysed by gel electrophoresis 
on a 1% agarose gel at 100 V for 40 minutes. SybrSafe dye was used for visualisation at 
280 nm. Products were used for the second PCR reaction. The generic primers used were: 
Forward: 5' – GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC GAA AAC CTG 
TAT TTT CAG  GGC  AGC CGC GCG – 3' 
Reverse: 5' – GGGG AC CAC TTT GTA CAA GAA AGC TGG GTG – 3' 
The bold section introduces the attB sites to the linear fragment produced by reaction 1. 
This reaction contained: 
PCR 1 product   1 µl 
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dNTP mix    4 µl 
5X PrimeSTAR® Buffer  10 µl 
Generic primer (forward)  1.5 µl 
Generic primer (reverse)  1.5 µl 
PrimeSTAR® HS Polymerase  0.5 µl 
dH2O     to 50 µl 
The reaction was run in the same thermocycler as the previous reaction, with the 
parameters: 
 
Step   Temperature   Time   
Initial Denaturation 94°C   10 min   
10 Cycles of: 
Denaturation  94°C   20 sec   
Annealing  45°C   5 sec   
Extension  72°C   1 min  
20 Cycles of:  
Denaturation  94°C   15 sec   
Annealing  45°C   5 sec   
Extension  72°C   1 min   
Final Extension 72°C   2 min   
Hold   4°C   -   
Products were analysed by gel electrophoresis on a 1% agarose gel at 100 V for 40 minutes. 
SybrSafe dye was used for visualisation at 280 nm. 
7.2.2 Cloning of TaqPRDX1 into pDONR221 donor plasmid 
Product from PCR reaction 2 was inserted into the donor plasmid pDONR 221 using the BP 
reaction (3.2). The reaction mixture contained: 
PCR 2 product  2.5 µl 
pDONR 221 plasmid  0.5 µl 
BP clonase II   1 µl 
dH2O    1 µl 
This was incubated at room temperature for 5 hours. Proteinase K was then added to digest 
the clonase enzyme, and the reaction was incubated at 37°C for 10 minutes.  
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7.2.3 Transformation of pDONR221 plasmid into E.coli DH5α 
Plasmids were then transformed into electro DH5α E. coli cells using a Bio-Rad 
MicropulserTM in a 0.2 cm electroporation cuvette. 1 ml of LB medium (10 gl-1) was added 
and cells were incubated at 37°C for 1 hour, then plated on an LB/Agar + Kan and incubated 
at 37°C overnight. Single colonies were selected to inoculate 10 ml LB + Kan cultures, which 
were incubated at 37°C overnight with shaking at 160 rpm. 
7.2.4 BsrG1 digest of pDONR221 plasmid 
Plasmids were extracted (5.3) and digested using the restriction enzyme BsrG1 to determine 
if the gene insertion was successful. The reaction mixture was: 
pDONR211 plasmid  5 µl 
BSA    1 µl 
10x 'Buffer 2'   1 µl 
BsrG1 enzyme  0.5 µl 
dH2O    2.5 µl 
Reactions were incubated at 37°C for 2 hours, and products were analysed by gel 
electrophoresis using a 1% agarose gel ran at 100 V for 40 minutes. SybrSafe dye was used 
for visualisation at 280 nm. Samples containing inserts of an appropriate size were 
sequenced using an Applied Biosystems 9700 Gold Block thermal cycler. 
7.2.5 Cloning of TaqPRDX1 into pDEST 17 expression plasmid 
The gene was then cloned into the expression vector pDEST17, which adds an N-terminal 
His-Tag connected to the protein by a linker including a TEV protease cleavage site. The 
reaction mixture was: 
pDONR211 Plasmid  1 µl 
pDEST 17 vector  0.5 µl 
LR Clonase II   1 µl 
dH2O    2.5 µl 
The mixture was incubated at room temperature for 5 hours. Proteinase K was then added 
to digest the clonase enzyme, and the reaction was incubated at 37°C for 10 minutes. 
7.2.6 Transformation of pDEST17 into E.coli Rosetta 
Plasmids were transformed into electrocompetent Rosetta E. coli  cells by electroporation 
using a Bio-Rad MicropulserTM in a 0.2 cm electroporation cuvette. 1 ml of LB medium was 
added and cells were incubated at 37°C for 1 hour, and then plated on a LB/agar + Amp + 
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Kan plates and incubated overnight at 37°C. Plasmids were extracted (5.3) and insertion 
was confirmed using a BsrG1 and DNA sequencing (7.2.4). Freezer stocks were also 
produced (5.7). 
7.3 Overexpression and purification of TaqPrx 
Freezer stocks of E. coli Rosetta cells containing pDEST17 with the TaqPrx gene were 
cultured on an LB/agar + Amp + Kan plate overnight at 37°C. Single colonies were used to 
inoculate 10 ml LB + Amp + Kan cultures. These were grown overnight at 37°C, shaking at 
160 rpm. These cultures were used to inoculate 1 l LB + Amp + Kan cultures, which were 
grown at 37°C, shaking at 160 rpm until the OD600 reached ~0.6. Synthesis of TaqPrx was 
induced by adding IPTG to 0.3 mM and incubating cells at 26°C with 160 rpm shaking 
overnight.  
Cells were then harvested by centrifugation at 8000 rpm and resuspended in a low imidazole 
buffer (30 mM imidazole, 500 mM NaCl, 20 mM NaH2PO4, pH 7.5). Cells were lysed in a 
Microfluidics M-110P cell disrupter at 11500 bar, and cell debris was pelleted by 
centrifugation at 18000 rpm. Supernatant was loaded onto a 5 ml GE HisTrapTM FF Crude 
column, washed with low imidazole buffer and eluted using a high imidazole buffer (300 mM 
imidazole, 500 mM NaCl, 20 mM NaH2PO4, pH 7.5), collecting 1 ml fractions. Fractions were 
examined for protein content using a NanoDrop spectrophotometer measuring at 280 nm. 
Fractions containing protein were pooled and 1 mg of TEV protease (5.9) was added. This 
was then dialysed overnight into a cleavage buffer (20 mM Tris, 150 mM NaCl, 10 mM β-
mercaptoethanol, pH 7.5), then incubated for 1 hour at 37°C.  
Cleaved protein was separated from protease, cleaved His-tags and uncleaved protein using 
a 5 ml GE HisTrap FF Crude column, using low imidazole buffer to elute before washing any 
bound proteins from the column using high imidazole buffer. 1 ml fractions were collected 
and examined for protein using a NanoDrop spectrophotometer. Protein containing fractions 
were pooled and desalted into a low salt buffer (20 mM Tris, pH 8.0) using a 5 ml GE HiTrap  
26/10 desalting column. Cleaved protein was loaded onto a GE HiTrap Q Sepharose FF 
anion exchange column. Protein was eluted using a gradient of high salt buffer (20 mM Tris, 
1 M NaCl, pH 8.0). Samples containing TaqPrx were collected, then desalted into a storage 
buffer (20 mM Tris, 150 mM NaCl, pH 7.5) 
Samples from each step of the purification were examined by SDS-PAGE (5.8). 
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7.4 Protein melting temperature analysis 
The temperature of denaturation of TaqPrx was examined using a Bio-Rad iCycler iQ5. 25 µl 
samples were prepared in a 96 well plate, each containing 2.5 µl of 50× Sypro Orange 
protein dye and 22.5 µl of 1 mg/ml TaqPrx in 20 mM Tris, 150 mM NaCl, pH 7.5. Blanks 
were prepared containing 2.5 µl of 50× Sypro Orange protein dye and 22.5 µl 20 mM Tris, 
150 mM NaCl, pH 7.5 buffer. Both samples and blanks were run in triplicate, and heated 
from 20°C to 100°C, measuring fluorescence every 0.5°C. 
7.5 Dynamic light scattering measurement of TaqPrx 
Oligomeric state of TaqPrx was examined using a Malvern Zetasizer Nano. Samples of 1 
mg/ml TaqPrx were desalted into phosphate buffered saline solution (137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4. 1 mM KH2PO4, pH 7.4). Six 1 ml samples were analysed, allowing 
the software to identify the correct attenuation level for the laser. Samples showing the 
highest level of agreement were combined and used for analysis. 
7.6 Structural homology modelling 
The online program SWISS-MODEL from ExPASy (www.swissmodel.expasy.org/) was used 
to model the structure of TaqPrx from its amino acid sequence (Arnold et al. 2006; Kiefer et 
al. 2009; Peitsch 1995). The amino acid sequence of TaqPrx was entered, and the modelling 
program run in automated mode, which allows the program to search the PDB for a 
sequence that aligns with the query on which to base its model. 
The accuracy of the model was examined using the QMEAN4 tool provided by SWISS-
MODEL (Benkert, Tosatto, and Schomburg 2008; Benkert, Biasini, and Schwede 2011) as 
well as structural alignment with other peroxiredoxin enzymes using the program PyMOL 
from DeLano Scientific. 
7.7 Sparse matrix crystal screening 
7.7.1 Initial screening 
A Hampton Research pre-crystallisation test was carried out in order to find the appropriate 
protein concentration for further screening. Two samples were prepared containing TaqPrx 
at a concentration of 10 mg/ml using a hanging drop method, with reservoir solutions of 0.1 
M Tris, 2.0 M (NH4)2SO4, pH 8.5 and 0.1 M Tris, 0.2 M MgCl (H2O)6, 30% (w/v) PEG 4000, 
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pH 8.5. Incubation overnight gave a light precipitate in both conditions, showing that 
concentration was appropriate for crystal screening. 
Robotic crystal screening was carried out using a Hamilton Robotics Cartesian Honeybee 
Nanodispensor at the University of Auckland. Screens were of in-house design, based on 
the Hampton Crystal Screen, Hampton Crystal Screen 2 and Hampton Index screen. Drops 
were examined after 24 hours using a Leica Microsystems optical microscope, then every 
two days over several weeks. 
Conditions that showed evidence of crystal structure were recorded. Fresh samples were 
prepared with similar conditions in order to find conditions that would promote larger crystal 
growth. The hanging drop vapour diffusion method was used in 24 well Hampton 
crystallisation plates. The conditions used are summarised in Table 7.1 and 7.2. 
1.1 M AmSO4 
pH 4.0 
1.2 M AmSO4 
pH 4.0 
1.3 M AmSO4 
pH 4.0 
1.4 M AmSO4 
pH 4.0 
1.5 M AmSO4 
pH 4.0 
1.6 M AmSO4 
pH 4.0 
1.1 M AmSO4 
pH 4.5 
1.2 M AmSO4 
pH 4.5 
1.3 M AmSO4 
pH 4.5 
1.4 M AmSO4 
pH 4.5 
1.5 M AmSO4 
pH 4.5 
1.6 M AmSO4 
pH 4.5 
1.1 M AmSO4 
pH 5.0 
1.2 M AmSO4 
pH 5.0 
1.3 M AmSO4 
pH 5.0 
1.4 M AmSO4 
pH 5.0 
1.5 M AmSO4 
pH 5.0 
1.6 M AmSO4 
pH 5.0 
1.1 M AmSO4 
pH 5.5 
1.2 M AmSO4 
pH 5.0 
1.3 M AmSO4 
pH 5.0 
1.4 M AmSO4 
pH 5.0 
1.5 M AmSO4 
pH 5.0 
1.6 M AmSO4 
pH 5.0 
Table 7.1 Fine screen of potential crystallisation conditions. All conditions contain 0.1 M CH3COONa. 
AmSO4 is (NH4)2SO4. 
1.7 M AmSO4 
pH 4.0 
1.8 M AmSO4 
pH 4.0 
1.9 M AmSO4 
pH 4.0 
2.0 M AmSO4 
pH 4.0 
2.1 M AmSO4 
pH 4.0 
2.2 M AmSO4 
pH 4.0 
1.7 M AmSO4 
pH 4.5 
1.8 M AmSO4 
pH 4.5 
1.9 M AmSO4 
pH 4.5 
2.0 M AmSO4 
pH 4.5 
2.1 M AmSO4 
pH 4.5 
2.2 M AmSO4 
pH 4.5 
1.7 M AmSO4 
pH 5.0 
1.8 M AmSO4 
pH 5.0 
1.9 M AmSO4 
pH 5.0 
2.0 M AmSO4 
pH 5.0 
2.1 M AmSO4 
pH 5.0 
2.2 M AmSO4 
pH 5.0 
0.2 M AmSO4 
24% mPEG2K  
0.2 M AmSO4 
26% mPEG2K 
0.2 M AmSO4 
28% mPEG2K 
0.2 M AmSO4 
30% mPEG2K 
0.2 M AmSO4 
32% mPEG2K 
0.2 M AmSO4 
34% mPEG2K 
Table 7.2 Fine screen of potential crystallisation conditions. All conditions contain 0.1 M CH3COONa, 
all conditions containing mPEG 2,000 are at pH 4.0. AmSO4 is (NH4)2SO4, mPEG2K is mPEG 2,000. 
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Crystal streaking was also used to try and seed growth of TaqPrx crystals (Stura and Wilson 
1991). A hair was run through droplets containing microcrystals, then consecutively through 
6 droplets of buffers that did not form microcrystals in the earlier screen. Microcrystals were 
streaked from two conditions, termed I and II. I was: 1.7 M (NH4)2SO4, 0.1 M CH3COONa at 
pH 4.5. II was 1.5 M (NH4)2SO4, 0.1 M CH3COONa at pH 4.0. Microcrystals from I and II 
were each streaked through four conditions. These are summarised in Table 7.3.  
1.1 M AmSO4 
pH 4.5 
1.3 M AmSO4 
pH 4.5 
1.1 M AmSO4 
pH 5.0 
1.3 M AmSO4 
pH 5.0 
Table 7.3 Fine screen of potential crystallisation conditions. All conditions contain 0.1 M CH3COONa. 
AmSO4 is (NH4)2SO4. 
 
7.7.2 JCSG+ and PACT screening 
A second sample of TaqPrx was prepared at screened at the Collaborative Crystallisation 
Centre in Melbourne, Australia. TaqPrx was used at 15 mg/ml in two screens, JCSG+ and 
(OTHER). A crystal produced by the screen was examined at the MX1 Beamline at the 
Australian Synchrotron in Melbourne, Australia. 
TaqPrx samples were prepared in condition similar to those that produced the observed 
crystals in an effort to produce larger and more useful crystals. Conditions used are 
summarised in Table 7.4. 
50 mM LiSO4 
40% PEG 400 
100 mM LiSO4 
40% PEG 400 
150 mM LiSO4 
40% PEG 400 
200 mM LiSO4 
40% PEG 400 
250 mM LiSO4 
40% PEG 400 
300 mM LiSO4 
40% PEG 400 
50 mM LiSO4 
45% PEG 400 
100 mM LiSO4 
45% PEG 400 
150 mM LiSO4 
45% PEG 400 
200 mM LiSO4 
45% PEG 400 
250 mM LiSO4 
45% PEG 400 
300 mM LiSO4 
45% PEG 400 
50 mM LiSO4 
50% PEG 400 
150 mM LiSO4 
50% PEG 400 
150 mM LiSO4 
50% PEG 400 
200 mM LiSO4 
50% PEG 400 
250 mM LiSO4 
50% PEG 400 
300 mM LiSO4 
50% PEG 400 
50 mM LiSO4 
55% PEG 400 
150 mM LiSO4 
50% PEG 400 
200 mM LiSO4 
50% PEG 400 
200 mM LiSO4 
50% PEG 400 
250 mM LiSO4 
50% PEG 400 
300 mM LiSO4 
50% PEG 400 
Table 7.1 Fine screen of potential crystallisation conditions. All conditions contain 0.1 M CH3COONa 
and are at pH 4.5. 
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7.8 Activity assay 
Purified TaqPrx was examined for evidence of peroxide reducing activity. This was done 
using mass spectrometry to determine if the purported reactive cysteine of the protein 
reacted with H2O2.  
Protein at 3 mg/ml was desalted using a Bio-Rad BioSpin desalting column into a reduction 
buffer (20 mM Tris, 1 mM β-ME at pH 7.5). This, and all other buffers used in the assay were 
made with ultrapure water to ensure the absence of any oxidants. Samples were incubated 
at room temperature for 30 minutes, then desalted into a storage buffer (20 mM Tris, pH 
7.5), leaving reduced protein in the absence of any oxidants. 
The first sample was made by adding NEM (N-ethylmaleimide) to 1 mM into a sample of 
reduced protein. The sample was incubated at room temperature for 10 minutes, before 
being desalted back into storage buffer. 
The second sample was made by adding H2O2 to 1 mM into a sample of reduced protein. 
This was incubated at room temperature for 10 minutes, and then desalted into storage 
buffer. Following this, NEM was added to 1 mM and the sample was incubated at room 
temperature for a further 10 minutes. Finally protein was desalted back into storage buffer. 
The third sample was reduced protein in the storage buffer. 
The concentration of all samples was examined using a NanoDrop spectrophotometer 
measuring at 280 nm. All samples were diluted in storage buffer to a concentration of ~1 
mg/ml and analysed by mass spectrometry using a Bruker maXis 3G mass spectrometer to 
look for differences in molecular weights of the species present. 
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